Clemson University

TigerPrints
All Dissertations

Dissertations

May 2019

Glucose Adaptation and Glycosome Import
Machinery of Trypanosoma brucei
Logan Phillip Crowe
Clemson University, lpcrowe@clemson.edu

Follow this and additional works at: https://tigerprints.clemson.edu/all_dissertations
Recommended Citation
Crowe, Logan Phillip, "Glucose Adaptation and Glycosome Import Machinery of Trypanosoma brucei" (2019). All Dissertations. 2383.
https://tigerprints.clemson.edu/all_dissertations/2383

This Dissertation is brought to you for free and open access by the Dissertations at TigerPrints. It has been accepted for inclusion in All Dissertations by
an authorized administrator of TigerPrints. For more information, please contact kokeefe@clemson.edu.

GLUCOSE ADAPTATION AND GLYCOSOME IMPORT MACHINERY OF
TRYPANOSOMA BRUCEI

A Dissertation
Presented to
the Graduate School of
Clemson University
In Partial Fulfillment
of the Requirements for the Degree
Doctor of Philosophy
Biochemistry and Molecular Biology
by
Logan Phillip Crowe
May 2019
Accepted by:
Meredith Morris, Committee Chair
Lesly Temesvari
Cheryl Ingram-Smith
Lukasz Kozubowski

ABSTRACT

Trypanosoma brucei is the protozoan parasite responsible for Human African
Trypanosomiasis (HAT) and the cattle wasting disease Nagana endemic to sub-Saharan
Africa.

T. brucei and other kinetoplastids possess specialized peroxisomes called

glycosomes

that

compartmentalize

many

processes

including

glycolysis

and

gluconeogesis. While most studies on T. brucei has been performed on lab-adapted 2913 strain parasites, it has been observed that glucose is an important signaling cue for
differentiation of AnTat1.1 cells. Currently, most parasites are maintained in the glucoserich medium SDM-79, and studies using low glucose media have used either SDM-80 or
SDM-79 in which glucose has been depleted by cell culture. Both of these solutions pose
a problem by confounding the effect of glucose alone. Here, I present differences in cell
morphology, gene expression and glycosome composition between SDM-79 and SDM79θ as well as between strains. These results show that strain variation and culture
conditions are important considerations in the study of T. brucei. Because all glycosomal
matrix proteins are imported post-translationally and translocated into the organelle matrix
by the docking and translocation module (DTM) comprised primarily of Pex13 and Pex14.
Unique to kinetoplastids is the presence of two highly different (<20% similarity) Pex13s,
Pex13.1 and Pex13.2. Here, I analyze the role of TbPex13.2 in the import process. We
found that knockdown of TbPex13.2 under our conditions did not lead to a growth defect,
however, it did result in mislocalization of PTS2 harboring proteins, suggesting a role in
the PTS2 import pathway. Additionally, I examine the organization of the unique docking
complex. Because kinetoplastids have two Pex13s, the organization of the docking and
transport module (DTM) and specific function of each Pex13 unclear. I provide evidence
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that TbPex13.1 and TbPex13.2 are present in the same organelles and directly interact.
Because glycosomes are essential organelles, understanding mechanisms for their
biogenesis and protein import are crucial for better targeting the organelles for treatment
of disease caused by kinetoplastid parasites.
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CHAPTER ONE
Literature review

Human African Trypanosomiasis
Human African Trypanosomiasis (HAT), also known as African Sleeping Sickness,
is caused by the extracellular parasite Trypanosoma brucei and is present across subSaharan Africa (1). T. brucei is passed between the tsetse fly (Glossina spp.) insect vector
and mammalian hosts (1). There are three subspecies of Trypanosoma brucei: T.b.
gambiense and T.b. rodesiense, which are capable of infecting humans, while the third,
T.b. brucei primarily infects cattle causing the wasting disease Nagana (1–3). Of the three
subspecies of T. brucei, T.b. gambiense is responsible for a majority of cases of HAT,
resulting in the chronic form of the disease found across western Africa (1, 4). Due to lack
of proper reporting in these regions of Africa, accurate numbers of annual cases are
difficult to determine; however, it is estimated that as of the 2013 World Health
Organization study, there are 70 million people at risk with approximately 20,000 new
cases each year and estimates of 3 million cattle deaths by the Food and Agriculture
Organization of the United Nations (http://www.fao.org), which places a heavy economic
burden (approximately US $1 – $1.2 billion per year) on the region (1, 5, 6).
Unlike T.b. gambiense and T.b. rodesiense, humans are typically immune to T.b.
brucei due to the presence of trypanosome lytic factor (TLF), a high density lipoprotein
(HDL), which causes parasite lysis upon endocytosis and trafficking of HDL to the
lysosome (7, 8). TLF is composed of both lipid and protein, the functional components of
which, apolipoprotein L-I (ApoLI) and haptoglobin-related protein (Hpr), are responsible
for trypanosome lysis (9, 10). Both T.b. gambiense and T.b. rodesiense express serum
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resistance associated protein (SRA) which binds to and inactivates ApoLI, conferring
resistance to the lytic factor (7). Because T.b. brucei is sensitive to expression of ApoLI,
it is an ideal species for study of Trypanosomatids as it is relatively non-infectious.
The first stages of T.b. rodesiense infection are characterized by acute symptoms
including: irritation of skin near the site of infection, edema, and tenderness.

T.b.

gambiense causes a chronic infection with symptoms including fever, headaches, skin
lesions, and enlarging of lymph nodes, spleen and liver (4). These early stages, if
detected early, are typically treated with pentamidine, requiring multiple 2 hour blood
infusions over the course of 7 days (4, 11). If infection proceeds into the central nervous
system, treatment becomes more complicated and current treatments call for a
combination therapy of Eflornithine and Nifurtimox requiring multiple doses over the
course of two weeks; however, resistance against these drugs has been growing and it is
not effective against T.b rodesiense infection (4, 11) . In the case of drug resistance,
treatment with Melarsoprol, an arsenic derived drug is used, which is painful and results
in death of 10% of patients due to treatment alone (4, 11).

Trypanosoma brucei life cycle
Trypanosoma brucei has a complicated life cycle as it is passed between the insect
vector and the mammalian host (Figure 1.1) (12).

Procyclic form (PF) parasites exist

within the tsetse fly midgut and are suitable for in vitro cell culture. PF parasites are a
proliferative life cycle stage characterized by a procyclin acidic repeat protein (PARP)
surface coat, active mitochondrion, and elongated body (13, 14). Following PF invasion
of the insect midgut, the parasites migrate to the salivary glands where they differentiate
into metacyclic form parasites characterized by their non-proliferative nature, attachment
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to the epithelial cells of the salivary glands, and pre-adaptation for transmission to the
mammalian host (13, 14).
Upon the insect vector taking a blood meal on the mammalian host, the preadapted metacyclic parasites are introduced to the bloodstream where they differentiate
into bloodstream form (BSF) parasites characterized by the presence of a variable surface
glycoprotein (VSG) coat for immune evasion, significant reduction in mitochondrial activity
and size, and reliance on glycolysis for ATP production (13–17). In the bloodstream, the
parasites exist as either the long slender form, which are proliferative, or differentiate into
short stumpy form parasites that are non-proliferative and pre-adapted for life in the insect
vector (5, 12, 13). The long slender bloodstream form parasites are suitable for in vitro
cell culture; however due to their non-proliferative nature, short stumpy form parasites
cannot be continuously cultured in vitro. Recent work has shown that T. brucei can
accumulate within adipose tissue as adipose tissue form (ATF) and in the skin, which may
serve as a reservoir for reinfection following clearing of BSF parasites (12, 18). Following
ingestion by the insect vector, the short stumpy form parasites differentiate into PF
parasites, completing the life cycle.
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Figure 1.1: Life cycle of Trypanosoma brucei
Life cycle showing the development of T. brucei as it is transmitted between the insect
vector and the mammalian host. Further recent findings have also observed T. brucei
infection in the skin of the mammalian hosts (18). The parasites encounter multiple
environments with highly variable nutrient availability. Permission granted under Creative
Commons Attribution License (CC BY) (12).
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Trypanosoma brucei cell structure
Trypanosoma brucei was described in detail by J. Everett Dutton in 1902 following
his identification of the parasite in human blood, a parasite which was previously thought
to only infect cattle (3). He described the parasite as a very small worm-like organism with
an anterior flagellum that is attached to the cell body via an undulating membrane. Dutton
also identified what would later be known as the kinetoplast near the posterior end of the
cell. The kinetoplast is a network of mitochondrial DNA arranged in interconnecting rings
found at the base of the flagellum and basal body, and is a defining characteristic of
kinetoplastids, giving the class its name (19). Distributed throughout the cell are unique
organelles known as glycosomes that are related to peroxisomes (20, 21). Cell structure
of T. brucei is shown in Figure 1.2.

Figure 1.2: Cell structure of Trypanosoma brucei
Diagram showing the cell structure of T. brucei. 1. Nucleus; 2. Kinetoplast; 3. Flagellar
pocket; 4. Basal body; 5. Flagellum; 6. Golgi; 7. Endoplasmic reticulum; 8. Mitochondrion;
9. Glycosomes; 10. Ribosomes; 11. Lysosome; 12. Endosomes.
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Peroxisomes
Peroxisomes are small (0.1 – 1 μm in diameter), single-membrane bound
organelles that were first discovered by Rhodin in electron micrographs of mouse kidney
cells in 1954 and orgininally named microbodies (22, 23). Peroxisomes do not possess
their own DNA, and as such must import all matrix proteins post-translationally (23, 24).
Peroxisomes are present in most eukaryotic organisms and carry out multiple roles. The
hallmark reactions of peroxisomes are β-oxidation of fatty acids and peroxide degradation
by catalase (23). Although these functions are common to most organisms, they are not
characteristic of all organisms.

For example, the specialized peroxisomes of

kinetoplastids, do not possess catalase (25). Peroxisomes serve different functions in
different organisms and contain many pathways including:

Purine biosynthesis,

isoprenoid synthesis, amino acid metabolism, glycolysis, glyoxylate cycle, and firefly
luciferase (Figure 1.3) (23, 26).
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Figure 1.3: Peroxisomes have various functions
The function of peroxisomes is specialized to suit the individual organisms. Reprinted with
permission from Elsevier, Molecular and Biochemical Parasitology (Peroxisomes in
parasitic protists: Toni Gabaldón, Michael L. Ginger, and Paul A.M. Michels) Copyright:
Elsevier, 2016. (26)
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Peroxisomes are responsive to environmental cues and may alter their size and
protein composition, and are heterogenous organelles (27–29). Work done using the
model organism Saccharomyces cerevisiae has shown that growth on minimal media
containing oleate as the primary carbon source results in proliferation of peroxisomes (30–
32). Peroxisomes are the sole site of β-oxidatiative metabolism in S. cerevisiae, and as
such, growth on a medium with oleate as the sole carbon source relies on processes
contained within the organelle (31, 33).

Similarly, in mammalian cells peroxisome

proliferation can be activated in response to nutrient metabolism.

For example,

peroxisome proliferation is regulated by a class of transcriptional factors known as
peroxisome proliferator-activated receptors (PPARs) (34, 35). Using murine models, it
was shown that PPARα plays a role in cellular response to fasting, resulting in increased
fatty acid metabolic pathways (36).
It is hypothesized that the environmental responsiveness of peroxisomes is related
to organelle turnover and biogenesis. The primary pathway for peroxisome degradation
is called pexophagy and occurs when peroxisomes fuse with a lysosome to form an
autophagosome, resulting in organelle degradation (37). In contrast, new organelles can
be formed by two routes: de novo biogenesis and the growth and division of existing
organelles (Figure 1.4) (23).
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Figure 1.4: Biogenesis pathways for peroxisomes
Peroxisomes can be formed in either a de novo process in which pre-peroxisomal vesicles
containing peroxisomal membrane proteins (PMPs) bud from the ER (V1, V2, and V3) and
fuse in the cytosol to form a mature peroxisome or by the growth and division of existing
organelles through a process of importing matrix proteins, receiving membrane from ERderived vesicles and fission through the action of dynamin related proteins (DRPs).
Reprinted with permission from Springer Nature, Nature Reviews Molecular Cell Biology
(Peroxisomes take shape: Jennifer J. Smith and John D. Aitchison) Copyright: Springer
Nature, 2014. (23)
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The growth and division of existing organelles is the best understood mechanism
for the formation of new peroxisomes. In this pathway, mature peroxisomes continuously
import matrix proteins from the cytosol and receive membrane derived from the ER by
vesicle transport (23). Division of peroxisomes occurs by elongation of the membrane
followed by constriction of the neck by the actions of Pex11 and dynamin related proteins
(DRPs) (23, 38).
In one model of de novo biogenesis, pre-peroxisomal vesicles containing either
Pex13 and Pex14 (docking complex) or Pex2, Pex10, and Pex12 (RING-finger domain
containing proteins) are formed in the ER through a mechanism mediated by Pex3 and
Pex19 (Figure 1.4) (23, 38). These pre-peroxisomal vesicles are not import-competent on
their own, but fuse in the cytosol to create an import-competent organelle with the
complete import machinery (23, 24, 38). Because the organelles formed by this pathway
lack matrix proteins until the complete import machinery is in place, regulation of new
matrix protein import can specialize the new organelles.

Glycosomes – Specialized peroxisomes
Glycosomes, first described in 1977,

are specialized peroxisomes unique to

kinetoplastids (20). Compartmentalization of glycolysis within the glycosome gives the
organelle its name; however, there are many processes that are compartmentalized within
the organelles (Figure 1.5) (39). Multiple hypotheses for the purpose of the glycolytic
compartmentalization exist. One possible explanation for the compartmentalization of the
pathway is the lack of feedback inhibition on many of the key regulatory steps in glycolysis.
Although hexokinase (HK) and phosphofructokinase (PFK) are subject to inhibition by their
products in most organisms, TbHK and TbPFK are not allosterically regulated (40).
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Because glucose is highly abundant in the cytosol, loss of compartmentalization of TbHK
results in ATP depletion as all available glucose is phosphorylated, resulting in cell death
in a process that has been described as “turbo-explosion” (41). A second hypothesis is
that compartmentalization allows for streamlining of glycolysis by allowing the glycolytic
enzymes to be in close proximity to each other, and allows for rapid remodeling of
metabolic pathways due to changes in environment (42, 43).
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Figure 1.5: Metabolic pathways of glycosomes
Glycosomes

compartmentalize

multiple

metabolic

functions

including

glycolysis/gluconeogenesis (green), pentose phosphate pathway (pentose phosphate
pathway), trypanothione cascade (brown), ester lipid biosynthesis (red), and fatty acid
metabolism (blue). Reprinted with permission from Elsevier, The International Journal of
Biochemistry & Cell Biology (Glycosomes: A comprehensive view of their metabolic roles
in T. brucei.: Stefan Allmann and Frédéric Bringaud) Copyright: Elsevier, 2017. (44)

T. brucei strains respond differently to extracellular glucose
Procyclic form (PF) parasites within the insect vector midgut only have transient
access to glucose immediately following a bloodmeal; however, proline is abundant within
the insect midgut, and the parasites primarily use amino acid metabolism for production
of ATP (13, 45, 46). Although proline is the primary carbon source for PF parasites, lab
adapted strains such as 29-13 strain cells will preferentially use glucose if it is available
(47, 48). More recent work suggests that pleomorphic AnTat1.1 strain parasites that were
differentiated in vitro to PF initially do not grow well in the presence of glucose, suggesting
strain variation in response to environmental conditions (49). Due to continuous culture,
29-13 and other lab adapted strains have lost the ability to differentiate; however, they are
routinely used for study as they are more amenable to genetic manipulation because they
express T7 polymerase and Tet repressor, allowing for inducible expression of transgenes
and RNA interference (RNAi). The pleomorphic strains of T. brucei are beneficial for the
study of differentiation or infection, but are not as easily manipulated (50). In contrast to
PF parasites, BSF parasites are bathed in constant 5 mM glucose in the mammalian blood

12

stream and use glycolysis for ATP production and begin to die within 12 hours of glucose
removal (51).
Because T. brucei encounters multiple environments with different nutrient
availabilities, parasites must quickly modify metabolic processes. Glycosomes are highly
dynamic with respect to matrix protein composition, and compartmentation within the
organelles allows for rapid changes in response to environmental cues. During the
process of differentiation from BSF to PF, that a large percentage of glycosomes
associated with lysosomes, suggesting that organelle turnover occured via pexophagy
(52). In culture conditions, removal of glucose from culture media influenced expression
of a fluorescent glycosome marker protein (43).

These data suggest that

compartmentalization of metabolic pathways in the glycosomes allows for enhanced
regulation of protein expression and rapid response to environmental changes.

Peroxins regulate peroxisome dynamics
Like peroxisomes, glycosome dynamics are regulated by a family of proteins
known as peroxins, which includes over 30 proteins in higher eukaryotes (23). Although
there is significant variation in the primary structure of peroxins across species, the
general functions of the proteins are conserved. The role of peroxins varies and includes:
organelle biogenesis, growth and division of existing organelles, membrane protein import,
matrix protein import, shuttling of import receptors back to the cytosol, and organelle
inheritance (53–60). Although these functions are present in all organisms that possess
peroxisomes, there are some unique peroxins that are specialized for certain tasks.
An example of a specialized peroxin is Pex17p found in Yarrowia lipolytica and
Saccharomyces cerevisiae (23, 61, 62). Pex17p is a peripheral membrane protein that
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interacts with Pex14 and is involved in the import of a subset of peroxisomal matrix
proteins (61, 62). Deletion of Pex17 resulted in mislocalization of several peroxisomal
proteins in Y. lipolytica such as isocitrate lyase and catalase, but not malate synthase or
acyl-CoA oxidase (61).
Another example of a unique peroxin is Pex16 that is found in mammals and
kinetoplastids, but is absent in yeast (23, 63). Pex16 functions in peroxisomal membrane
assembly in conjunction with Pex3 and Pex19 by mediating trafficking of Pex3 and PMP34
from the ER (64). Deletion of Pex16 in Chinese hamster ovary (CHO) cells resulted in
loss of peroxisomal structures, with Pex3 mislocalizing to mitochondria. Thus, Pex16 is
thought to contribute to membrane assembly of early peroxisomes in the de novo
biogenesis pathway by functioning in Pex3 targeting (65).

Peroxisome protein import
In addition to organelle formation, peroxins are also involved in protein import into
the peroxisomes. Peroxisomes do not contain their own DNA and proteins are imported
post-translationally (23). Peroxisomal membrane proteins (PMPs) are identified by the
cytosolic receptor Pex19 via an internal Pex19 binding site, and are delivered to the
peroxisomal receptor Pex3 for import into the peroxisome membrane (66–68).
Peroxisomal matrix proteins are also recognized by cytosolic receptors and are imported
into the organelles fully-folded (38, 69–71). There are multiple pathways for the import of
peroxisomal matrix proteins: peroxisomal targeting sequence 1 (PTS1) mediated, PTS2
mediated, or by “piggy-backing” (24, 72).
Both PTS1 and PTS2 mediated import begin after translation on free ribosomes,
and the targeting sequences are recognized by Pex5 and Pex7, respectively (Figure 1.6)
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(73–75). PTS1 is a C-terminal tripeptide with the consensus sequence of S-K-L and PTS2
is an N-terminal nonapeptide with a more varied consensus sequence of R/K-L/H/V-X5Q/H-L/A (76, 77). Some peroxisomal proteins do not possess a PTS, and are imported in
a piggy-back mechanism through interactions with other matrix proteins that harbor a PTS
(78). After recognition by the cytosolic receptors, the cargo is transported to the membrane
docking complex comprised primarily of Pex13 and Pex14 (79–81). It is hypothesized that
Pex13 functions in recognition of the cytosolic receptors; however, the exact role of Pex13
is not well understood. Import of the fully folded matrix proteins is accomplished by a
contractile pore formed by Pex14 and Pex5 in PTS1 import or alternative accessory
peroxins in PTS2 import (74). After translocation into the organelles, Pex5 is recycled to
the cytosol by the action of the RING complex (Pex2, Pex10 and Pex12), and Pex7 is
degraded (24, 82, 83).
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Figure 1.6: Protein translocation into peroxisomes of S. cerevisiae.
(A) Proteins harboring peroxisomal targeting sequences (PTS1 or PTS2) are translated
on cytosolic ribosomes, and identified by the cytosolic receptors Pex5 or Pex7,
respectively. (B) The cytosolic receptors direct the cargo to the docking and translocation
complex comprised primarily of Pex13 and Pex14, with various accessory proteins such
as Pex17. (C) The cytosolic receptor and Pex14 form a pore for protein translocation. (D)
Pex5 is ubiquitinated by the RING complex comprised of Pex2, Pex10, and Pex14 with
the action of the Pex4 and Pex22, and is then returned to the cytosol by Pex1, Pex6, and
Pex15 (E). (F) Pex5 is deubiquitinated in the cytosol. Permission granted under Creative
Commons License (CC BY) (84).
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Kinetoplastids possess two unique Peroxin 13s
Pex13 is a member of the docking complex and is hypothesized to recognize the
cytosol receptor-cargo complex (79, 84–87). Unique to kinetoplastids is the presence of
two distinct Pex13s that have been named Pex13.1 and Pex13.2 (87, 88). Although the
primary structure of Pex13 is not highly conserved between species, its overall domain
structure is maintained. Pex13s generally possess three main characteristics: an Nterminal YG rich region, two transmembrane domains, and a C-terminal SH3 domain
(Figure 1.7) (88). While conventional BLAST searches were unable to find matches in
kinetoplastids, a search for proteins possessing typical Pex13 domains led to the
identification of TbPex13.1 (87). TbPex13.1 maintains the domain structure of other
known Pex13s; however, it also possesses a PTS1 at the C-terminus, which is unusual
for a peroxisomal membrane protein. Following the identification of TbPex13.1, newer
methods based on hidden Markov model (jackhammer) were able to identify a second
Pex13 in kinetoplastids using the known Pex13 sequences from human, Arabidopsis, and
yeast (88). Although TbPex13.2 is predicted to possess two transmembrane domains and
the N-terminal YG rich region, it lacks the SH3 domain and has low sequence similarity
with TbPex13.1 (< 20% similarity) (88).
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Figure 1.7: Domain similarity between identified Pex13s
Diagram of the primary structure of yeast, animal, plant, and trypanosomatid Pex13s.
TbPex13.1 maintains overall domain structure that is common among yeast and animals
but also possesses an unusual PTS1. TbPex13.2 lacks the C-terminal SH3 domain but
retains the two predicted transmembrane domains and YG rich region. Reprinted with
permission from John Wiley and Sons, FEBS Letters (Trypanosomes contain two highly
different isoforms of peroxin PEX13 involved in glycosome biogenesis) Copyright: John
Wiley and Sons, 2012. (88)

Both TbPex13.1 and TbPex13.2 localize to glycosomes in kinetoplastids and are
implicated in matrix protein import (87, 88). It is believed that the interaction between
Pex13 and Pex14 is mediated through a combination of the SH3 domain of Pex13 with
the PXXP motif of Pex14 and an intraperoxisomal binding site that was identified in yeasttwo hybrid assays where the PXXP motif was replaced with AXXA to disrupt interaction
(79, 86). In addition to the Pex13-Pex14 interaction, Pex13 interacts with Pex5 at the SH3
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domain and with Pex7 at the N-terminal YG-rich region (79, 85, 86). Because TbPex13.1
shares similar domain structure to other known Pex13s, it is likely that the interactions with
other peroxins are similar; however because TbPex13.2 lacks the SH3 domain, it is
hypothesized that interaction with TbPex14 is primarily mediated through the internal
intraperoxisomal binding site and Pex5 interaction is absent.

Summary
In the following chapters, I present work on the impact of glucose on Trypanosoma brucei
in both the lab adapted 29-13 monomorphic strain as well as the pleomorphic AnTat1.1
strain. In Chapter Two, I demonstrate that extracellular glucose impacts glycosome
composition and morphology and induces mitochondrial morphological changes only in
AnTat1.1 cells. I also show that when cultured in the same media conditions, 29-13s and
AnTat1.1 parasites differentially express over 10% of detected transcripts. In Chapter
Three, I analyze the role of Pex13.2 in the import complex. I show that the N-terminus of
Pex13.2 containing the YG-rich region is exposed to the cytosol and that knockdown using
RNAi results in mislocalization of a subset of glycosomal matrix proteins. In Chapter Four,
I present evidence that Pex13.1, Pex13.2, and Pex14 interact and are likely members of
the same complex. I hypothesize that multiple docking complexes are possible and may
contribute to glycosome specialization at the matrix protein import level.
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Abstract
Trypanosoma brucei, the parasite responsible for Human African Trypanosomiasis (HAT),
also known as sleeping sickness, has a complex life cycle that inhabits several unique
environments. Within a mammalian host, the bloodstream form (BSF) parasites have
constant access to 5 mM glucose and rely on glycolysis for the production of ATP.
Recently, parasites have been detected in skin and adipose tissue (ATF), both of which
are low glucose environments. In the insect vector midgut, procyclic form (PF) parasites
do not have access to glucose apart from temporary spikes following a bloodmeal. T.
brucei, like other kinetoplastids, has unique and essential organelles called glycosomes
that compartmentalize many metabolic pathways including glycolysis. Previous work has
shown that expression of a glycosomally-targeted fluorescent reporter was sensitive to
changes in extracellular glucose levels; however, the mechanisms for these
environmentally induced changes is not known. Most glycosome studies in procyclic form
parasites are performed in 29-13 parasites or similar lab adapted strains for which genetic
tools are available; however, these cells have become adapted to high glucose conditions
due to decades of culturing in glucose-rich media. In contrast, a pleomorphic cell line,
AnTat1.1 that is capable of differentiation between PF and BSF responds differently to
changes in extracellular glucose availability. In high glucose conditions, the expression of
a fluorescent glycosome reporter protein (PTS2eYFP) was increased in comparison to
cells grown in low glucose conditions. We also observed that interparasite PTS2eYFP
expression level variability was higher in AnTat1.1 as compared to 29-13 and distribution
of PTSeYFP among glycosomes within a single parasite is heterogeneous. Interestingly,
TEM analysis revealed that glycosome size and number were increased in low-glucose
conditions. Furthermore, RNAseq and proteomic analysis indicated that the transcriptome
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and proteome are influenced by extracellular glucose and that 29-13 and AnTat1.1 cells
responded to these changes differently. These findings demonstrate that extracellular
glucose levels and strain variation result in significant differences in glycosome,
composition, organelle morphology, as well as transcriptome and proteome expression,
and must be an important consideration for future studies.
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Introduction
Trypanosoma brucei is the protozoan parasite responsible for Human African
Trypanosomiasis (HAT). Throughout the life cycle of T. brucei, the parasite encounters
varying environmental conditions as it is transmitted between the tsetse fly insect vector
as the procyclic form (PF), and the bloodstream form (BSF) found in the mammalian host
(1). Both the PF and BSF life cycle stages are exposed to different environments and
must adapt to available energy sources. Within the tsetse fly midgut, glucose is only
available immediately following a bloodmeal and the parasites rely on amino acid
metabolism, primarily from proline, which is abundant in the insect midgut (1–3). During
brief periods of glucose availability, lab-adapted strains will preferentially utilize glucose
as a carbon source (1, 3–5). Once transmitted to the mammalian host, the parasites
differentiate into BSF, have access to a constant supply of glucose and rely on glycolysis
for ATP production (6–10). Recent work has identified T. brucei in adipose tissue and
mammalian skin where glucose levels are relatively low (11, 12). Adipose tissue form
(ATF) parasites express transcripts associated with multiple metabolic pathways such as
glycolysis, pentose phosphate pathway, purine salvage, and β-oxidation. All of these
pathways are localized, in part, to the glycosome (11).

Multiple cell lines of T. brucei that can be cultured in the laboratory. The 29-13 parasite
cell line have been engineered to express the T7 polymerase and tet repressor, which
allow for inducible expression of transgenes and RNAi, making it an attractive model for
studies involving genetic manipulation (13). Additionally, these cells grow well in the lab;
however, they have lost the ability to differentiate between PF and BSF forms and
complete the life cycle (14). In contrast, pleomorphic strain parasites such as AnTat1.1
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are able to complete the life cycle; however, they are less amenable to genetic
manipulation. AnTat1.1 cells that are harvested from murine hosts can differentiate into
PF via glucose deprivation and are maintained in low-glucose conditions. In fact, unlike
29-13s that grow faster in high glucose media, glucose is inhibitory to AnTat1.1s. (15).
Because these cells respond differently to glucose and the metabolic pathways that are
likely responsible for these differences are localized to glycosomes, we wanted to resolve
how glycosome structure and composition changed with parasite strain and extracellular
glucose conditions.

In the lab, both PF and BSF parasites are usually cultured with 5 mM and 22 mM glucose,
respectively. BSF parasite cultures are maintained in glucose rich media such as HMI-9
(supplemented with 10% fetal bovine serum (FBS) and 10% serum plus) and removal of
glucose from BSF culture results in cell death (16). Although PF parasites spend most of
their time in low-glucose conditions, they are typically cultured in media containing 5 mM
glucose (17).

Trypanosoma brucei, among other kinetoplastids, possesses unique organelles that are
specialized peroxisomes called glycosomes (18, 19). These organelles compartmentalize
a majority of the glycolytic pathway in kinetoplastids and are essential for parasite survival
(18, 20–22). In most organisms, glycolysis occurs within the cytosol and the purpose for
compartmentalization of this process in kinetoplastids is unclear. Extracellular glucose is
toxic to PF cells in which glycosomes have been compromised and because BSF
parasites rely entirely on glucose for ATP production, disruption of glycosomes is lethal
(18, 20, 22).
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Although glycosomes are essential organelles that compartmentalize glycolysis, the
function of the organelles is plastic and the composition of BSF and PF glycosomes is
different. For example, a majority of the proteins involved in the pentose phosphate
pathway and purine salvage pathway are present in PF glycosomes, but not in BSF
glycosomes (9).

Additionally, studies have shown that PF glycosome composition

changes with extracellular glucose conditions (8). Although environmental conditions
impact glycosome composition, the mechanisms responsible for this are not known and
our understanding of the diverse nature of glycosomes is limited as most studies have
been performed in glucose-rich media such as SDM-79 (9, 25–27).

In this work, we report the effect of glucose availability on gene expression in PF T. brucei
strains 29-13 and AnTat1.1 using a glucose deplete (~5 μM) formulation of SDM-79,
named SDM-79θ. Because fetal bovine serum (FBS) contributes glucose to the media,
SDM-79θ uses dialyzed serum, eliminating glucose while maintaining similarity to SDM79. We compared the expression of glycosomal proteins between cells cultured in SDM79 and SDM-79θ and tracked glycosome dynamics by flow cytometry and immuno-EM
using a glycosome-targeted fluorescent reporter, AldoPTS2eYFP. During the adaptation
from SDM-79θ to SDM-79, we observed an increase in the expression of the glycosome
reporter and found that glycosome composition is more heterogenous in cells cultured in
SDM-79θ. Additionally, we used RNAseq and mass spectometry analysis to compare the
transcriptome and proteome of parasites grown in high and low glucose in pursuit of
understanding the influence of extracellular glucose levels on gene expression and how
the responses between 29-13 and AnTat1.1 strain parasites. We observed that in 29-13
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cells, 5.1% of the transcriptome was differentially regulated between SDM-79 and SDM79θ, while in AnTat1.1 cells, 12.8% of transcripts changed. In addition, when comparing
29-13 and AnTat1.1 grown in the same media, over 10% of the transcriptome was
differentially expressed. Approximately 30% of the proteome of each cell line changed
with extracellular glucose levels.

Here, we demonstrate the impact of culture conditions on glycosome composition and
morphology, as well as the global transcriptome and proteome. In addition, we show that
there is significant variation between the lab-adapted 29-13 strain and the pleomorphic
AnTat1.1 strain. Because of the impact of environmental conditions and strain selection,
it is essential to consider these factors when applying results between studies and to
parasites found in nature.
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Materials and Methods

Cell culture: Trypanosoma brucei 29-13 strain procyclic form parasites were maintained
in SDM-79 (Gibco, Table 1) supplemented with either 5 mM glucose and 10% FBS
(+Glucose, SDM-79) or 10% dialyzed FBS (-Glucose, SDM-79θ) and selected with G418
(15 μg/mL) and hygromycin (50 μg/mL). AnTat1.1 cells were isolated from murine blood,
differentiated in vitro and maintained in SDM-79θ. PTS2eYFP transfection was carried
out as described previously (8). PF PTS2eYFP were maintained in media containing
blasticidin (15 μg/mL). Daily cell density was determined by flow cytometry (Accuri C6) to
generate growth curves. Cultures were maintained between 105 and 107 cells / ml.

Western blot analysis: 5x106 cells were collected by centrifugation (800x g, 10 min) and
washed once with PBS and resuspended in SDS-PAGE loading buffer. Cell lysates were
separated on a 12% SDS-PAGE gel and transferred to a nitrocellulose membrane.
Membranes were blocked in 2% non-fat milk in 1x TNT (10 mM Tris-HCl, 150 mM NaCl,
0.05% Tween-20, pH 8.0). After blocking, primary antibody was applied. Antibodies used:
tubulin (1:20,000), TbPex13.1 (1:10,000), TbPex13.2 (1:10,000), Pex11 (1:4,000),
aldolase (1:20,000), phosphofructokinase (PFK) (1:10,000), fructose-1,6-bisphosphatase
(FBP) (1:10,000), hexokinase (HK) (1:100,000). Protein was detected with horseradish
peroxidase conjugated secondary antibody (1:10,000) and developed using SuperSignal
West Pico chemiluminescent substrate (ThermoFisher scientific).

Relative protein

concentration was determined by densitometry of western blots using ImageJ (NIH).
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SDM-79 adaptation analysis: Cells (29-13 and AnTat1.1) expressing an enhanced YFP
fused to the peroxisomal targeting sequence (PTS2) of aldolase were maintained in SDM79θ. Cells were passaged into SDM-79 media at 105 cells / ml in 10 ml media and
fluorescence intensity was measured by flow cytometry on a Beckman Coulter Cytoflex.
Events were gated for live cells on FSC-A vs SSC-A plot and intensity was plotted on a
FITC-area histogram. Measurements were done in triplicate and taken daily.

Live cell microscopy: Cells were collected by centrifugation (800x g, 10 min) and
washed once with PBS.

Cells were resuspended in PBS, mounted on slides, and

visualized on a Zeiss Axiovert 200M using Axiovision software version 4.6.3.

Electron microscopy: Cells (5x107) were harvested from either SDM-79 or SDM-79θ
and washed 2x with PBS.

Cells were fixed in 2.5% glutaraldehyde, 2%

paraformaldehyde in 100 mM phosphate buffer pH 7.4. Fixed cells were washed with
PBS, postfixed for 1 h in 1% osmium tetroxide (Polysciences Inc., Warrington, PA) and
washed with distilled water (dH2O). Cells were en bloc stained for 1 h with 1% aqueous
uranyl acetate (Ted Pella Inc., Redding, CA) and then washed with excessive dH2O. A
graded series of ethanol solutions was used to dehydrate samples.

Cells were

embedded in Eponate 12 resin (Ted Pella Inc.) and 90 nm ultrathin sections were
obtained using a Leica Ultracut UCT ultramicrotome (Leica Microsystems Inc.,
Bannockburn, IL). Sections were stained with lead citrate and uranyl acetate. A JEOL
1200 EX transmission electron microscope (JEOL USA Inc., Peabody, MA) was used to
image sections at the Molecular Microbiology Imaging Facility, Washington University
School of Medicine, St. Louis, MO.
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Measurements of glycosome size and cell area were performed using FIJI (28).
Glycosome area was calculated by outlining single organelles and measuring image
area. To calculate glycosome area as a percentage of total cell area, the sum area of
measured glycosomes was divided by total cell area measured.

Proteomics: Cells (5x106) were harvested from either SDM-79 or SDM-79θ, washed 2x
with PBS, flash frozen and stored at -80oC. Cell lysates were run on NuPAGE Bis-Tris 412% gradient gel (ThermoFisher). Each SDS-PAGE gel lane was sectioned into 12
segments of equal volume. Each segment was subjected to in-gel trypsin digestion as
follows.

Gel slices were destained in 50% methanol (Fisher), 100 mM ammonium

bicarbonate

(Sigma-Aldrich),

followed

by

reduction

in

10

mM

Tris[2-

carboxyethyl]phosphine (Pierce) and alkylation in 50 mM iodoacetamide (Sigma-Aldrich).
Gel slices were then dehydrated in acetonitrile (Fisher), followed by addition of 100 ng
porcine sequencing grade modified trypsin (Promega) in 100 mM ammonium bicarbonate
(Sigma-Aldrich) and incubation at 37oC for 12-16 hours. Peptide products were then
acidified in 0.1% formic acid (Pierce). Tryptic peptides were separated by reverse phase
XSelect CSH C18 2.5 um resin (Waters) on an in-line 150 x 0.075 mm column using a
nanoAcquity UPLC system (Waters). Peptides were eluted using a 30 min gradient from
97:3 to 67:33 buffer A:B ratio. [Buffer A = 0.1% formic acid, 0.5% acetonitrile; buffer B =
0.1% formic acid, 99.9% acetonitrile.] Eluted peptides were ionized by electrospray (2.15
kV) followed by MS/MS analysis using higher-energy collisional dissociation (HCD) on an
Orbitrap Fusion Tribrid mass spectrometer (Thermo) in top-speed data-dependent mode.
MS data were acquired using the FTMS analyzer in profile mode at a resolution of 240,000
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over a range of 375 to 1500 m/z. Following HCD activation, MS/MS data were acquired
using the ion trap analyzer in centroid mode and normal mass range with precursor massdependent normalized collision energy between 28.0 and 31.0.

Proteins and post-

translational modifications were identified by database search using Mascot (Matrix
Science) with a parent ion tolerance of 3 ppm and a fragment ion tolerance of 0.5 Da.
Scaffold (Proteome Software) was used to verify MS/MS based peptide and protein
identifications. Peptide identifications were accepted if they could be established with less
than 1.0% false discovery by the Scaffold Local FDR algorithm. Protein identifications
were accepted if they could be established with less than 1.0% false discovery and
contained at least 2 identified peptides. Protein probabilities were assigned by the Protein
Prophet algorithm (29).

RNAseq: Cells (5x106) were harvested (800 xg, 10 min) from either SDM-79 or SDM79θ, washed 2x with PBS, flash frozen and stored at -80oC. Total RNA was isolated using
Bio-Rad Aurum Total RNA Mini Kit. DNA was degraded with DNase I (RT, 15 min). RNA
was quantified using an Eon Microplate Spectrophotometer (BioTek) to confirm
A260/A280 values of ~2. RNAseq libraries were constructed using TruSeq Stranded
mRNA Library Prep Kit (Illumina) and normalized to 200 ng for input samples. Sequencing
was performed using either an Illumina HiSeq2500 (Hollings Cancer Center, Medical
University of South Carolina) with 2 x 125 paired-end reads or Illumina NextSeq550
(Genomics and Computational Laboratory, Clemson University) at 2 x 150 paired-end
reads.

Quality was assessed and adapter sequences removed using FastQC

(http://www.bioinformatics.babraham.ac.uk/projects/fastqc)

and

Trimmomatic

(30).

Reads were mapped to the T. brucei TREU927 reference genome without the 11 bin
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scaffold (http://tritrypdb.org) using GSNAP (31). Uniquely mapped, paired reads for each
gene were counted using Subread’s featureCounts (32). Differential gene expression was
calculated using the Bioconductor package edgeR (33, 34). GO Term enrichment was
determined using analysis tools available from Trytrypdb.org. Transcripts were analyzed
if they had a FDR < 0.05. Heatmaps were generated in R using the pheatmap package
using logFC of transcripts detected in each condition with a FDR < 0.05.
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Results

Trypanosoma brucei strains are cultured differently
PF 29-13 parasites have been maintained in glucose-rich media such as SDM-79 for
decades and have lost the ability to differentiate between PF and BSF. In contrast,
AnTat1.1 parasites can infect mice and differentiate in response to glucose depletion
(Figure 2.1) (15). Importantly, PF AnTat1.1 cells can be maintained in glucose deplete
SDM-79θ, which more closely resembles the environment in the insect vector (1, 15).

Figure 2.1. Schematic of 29-13 and AnTat1.1 culture history. 29-13 strain parasites
were maintained in glucose containing media for decades. In these experiments, mice
were infected with AnTat1.1 parasites. BSF cells isolated from blood, differentiated in vitro
using glucose depletion, and maintained in SDM-79θ (15).

Formulation of a consistent glucose deplete media
Fluorescent proteins fused to peroxisome targeting sequences (PTSs) have been used to
follow peroxisome biogenesis in mammals and yeast (35–37) and we adapted this system
to follow glycosome dynamics in trypanosomes (8). In those studies, we found that
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expression of enhanced yellow fluorescent protein fused to a PTS2 (PTS2eYFP) was
lower when cells were grown in SDM-80, a media used by multiple laboratories to mimic
low-glucose conditions (4, 8, 38, 39). Over time we found that growth in this media was
not predictable and we attribute this to lot-to-lot variation in media components.

In an

effort to increase reproducibility, we contracted with Gibco for large-scale media
preparation of a completely defined media (described in Table 2.1). In this transition, we
replaced SDM-80 with SDM-79q, which is identical to SDM-79 with the exception of
glucose levels (5 mM in SDM-79 and 0.5 μM in SDM-79q). We should note that glucose
concentration in SDM-79q is 0.5 μM while SDM-80 was 1 mM. This may be significant as
recent studies revealed that the reduction of glucose levels from 1 mM to 0.5 μM had
biological consequences and influenced whether BSF parasites could differentiate into PF
(15).

Glucose is stimulatory to 29-13 and inhibitory to AnTat1.1s. We first wanted to resolve
how glucose affected the growth of 29-13 and AnTat1.1 PF cells in culture. As reported
for multiple T. brucei strains (22, 40, 41), 29-13 PF cells grew faster in high-glucose media
with a doubling time of 13.5 h as opposed to minimal glucose where the doubling time was
15 h (Fig 2.2A). For AnTat1.1 cells, recently differentiated PF stabilates from liquid
nitrogen storage were thawed and grown for 3 days to recover in SDM-79q before being
passed into SDM-79. From days 1-3 growth rates for cells grown in SDM-79 and SDM79q were similar; however, cell growth of parasites grown in high-glucose was arrested
during days 3-7. Eventually, cells began growing at a steady-rate but still with longer
doubling times (33 h) as opposed to 16 h seen with cells grown in SDM-79q.
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Table 2.1.

Procylic media composition.

Components included in the custom

formulated SDM-79 and the glucose depleted variant SDM-79θ acquired from Gibco. Also
shown is the formulation of SDM-80 previously used in metabolic studies. Because FBS
is a significant contributor of glucose, SDM-80 contains approximately 1 mM glucose.

Figure 2.2: Addition of glucose to culture media results in changes in growth and
protein expression. (A) Growth curve of AnTat1.1 and 29-13 strain parasites in SDM-79
and SDM-79θ. Error bars represent standard deviation of 3 replicates. (B) Representative
western blot analysis of glycosomal proteins in AnTat1.1 and 29-13 cells in grown in SDM79θ or SDM-79.

FBP: fructose 1,6-bisphosphatase; PFK: phosphofructokinase; HK:

hexokinase. (C) Densitometry analysis of at least 3 replicate western blots.
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Expression of some glycosomal proteins is influenced by glucose.

Because

glycolysis is compartmentalized within glycosomes, we followed expression of several
glycosome proteins under varying glucose conditions by western blotting and analyzed by
densitometry (Fig. 2.2B). We chose the membrane peroxins Pex13.1, Pex13.2, and
Pex14 due to their role in glycosome matrix protein import, and the matrix proteins fructose
1,6-bisphosphatase (FBP), phosphofructokinase (PFK), aldolase, and hexokinase (HK)
due to their roles in glycolysis and gluconeogenesis. Western blot analysis of both 29-13
and AnTat1.1 cells showed that protein abundance of FBP was increased in SDM-79 and
PFK and HK protein was more abundant in SDM-79θ; however, expression of aldolase
was not affected by glucose availability. RNAseq analysis revealed that transcript levels
of these genes mirrored the protein expression patterns. FBP transcript was enriched by
0.40 logFC and 0.87 logFC in 29-13 and AnTat1.1, respectively, in SDM-79θ. PFK
transcript was enriched in SDM-79 by 0.75 logFC and 0.60 logFC in 29-13 and AnTat1.1,
respectively, and HK transcript was enriched by 2.54 logFC and 2.37 logFC in SDM-79 in
29-13 and AnTat1.1, respectively. These results were surprising to us as FBP is involved
in gluconeogenesis and PFK with glycolysis, and their expression was opposite of what
we predicted. Western blots revealed Pex13.1 and Pex14 proteins were less abundant in
SDM-79θ relative to SDM-79 and RNAseq showed the transcripts were also less abundant
in SDM-79θ. Pex13.2 protein expression was reduced in SDM-79θ by western blot, but
transcript was not detected in RNAseq data.
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Extracellular glucose affects expression of a fluorescent reporter protein.
To measure glycosome dynamics in live cells, we followed 29-13 and AnTat1.1 PF
parasites expressing AldoPTS2eYFP (enhanced YFP fused to the PTS2 of aldolase to
target the protein to glycosomes) in SDM-79 and SDM-79q by flow cytometry (Fig 2.3A).
In agreement with results observed with SDM-80, 29-13-AldoPTS2eYFP PF cells grown
in SDM-79 were brighter than cells grown in SDM-79q (8). The mean fluorescence of 2913 cells grown in SDM-79 was 5.68 x105, while those in SDM-79q were 4.05 x105.
AnTat1.1-AldoPTS2eYFP cells were also brighter in SDM-79 (6.63 x105) as opposed to
SDM-79q (1.18 x105); however, the difference in mean fluorescence intensity between
SDM-79θ and SDM-79 was greater. Additionally, the coefficient of variation (CV) values
for fluorescence was significantly higher in AnTat1.1s (106.51%) compared to 29-13s
(35.44%), suggesting that AldoPTS2eYFP expression levels between parasites are more
heterogenous in AnTat1.1 cells. Western analysis confirmed that AldoPTS2eYFP protein
expression is reduced in SDM-79θ (Fig 2.3B). To confirm this change in expression was
not due to the integration site of the constitutively expressed AldoPTS2eYFP marker, we
analyzed cells expressing cytosolic GFP which was integrated into the same genomic
locus. The expression of this protein was not affected by extracellular glucose levels (Fig
2.3C).

49

Figure 2.3:

Glucose availability affects levels of constitutively expressed

AldoPTS2eYFP. Cells expressing eYFP fused to the PTS2 of aldolase were cultured in
SDM-79θ and passed into SDM-79. (A) Histograms. Cells were passed from SDM-79θ
into SDM-79 and fluorescence intensity measured daily by flow cytometry. (B) Western
blot. Cell equivalents (2x106) was resolved by SDS-PAGE and analyzed by western
blotting with antibodies against aldolase and eYFP. Tubulin is shown as loading control.
(C) Western blot. Lysates from cells expressing cytosolic GFP were resolved by SDSPAGE and analyzed by western blotting using antibodies against GFP. Tubulin shown as
loading control.
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By flow cytometry, it is not possible to determine if the differences in fluorescence
intensities are a result of fewer glycosomes of equal fluorescence intensity or equal
number of glycosomes with different fluorescent intensities.

We used fluorescence

microscopy to discriminate between these two scenarios (Fig. 2.4A).

Because the

changes in relative fluorescence in 29-13-AldoPTS2eYFP PF were significant but small,
it was difficult discriminate between these two scenarios via fluorescence microscopy.
However, images collected from AnTat1.1-AldoPTS2eYFP cells suggest that this variation
in fluorescence intensities is not solely a reflection of differences in glycosome number.
AnTat1.1-AldoPTS2eYFP PFs grown in SDM-79 were 5-times brighter than those in SDM79q; however, we were unable to find cells with a similar variation in glycosome
fluorescence via fluorescence microscopy. There was, however, a noticeable difference
in the glycosome distribution of AnTat1.1 in SDM-79θ. In SDM-79, glycosomes appear to
be evenly distributed throughout the cell; however, in SDM-79θ, AnTat1.1 glycosomes
appeared to be more perinuclear.

Further analysis using immuno-EM detected more eYFP molecules per organelle in SDM79 in both 29-13 and AnTat1.1 cells (Fig 2.4B). In SDM-79θ, sixty percent of glycosomes
contained no gold particles and many had few (1-3) gold particles. In contrast, in SDM79 both cell lines had an increase in overall gold particles with many glycosomes
containing 6 or more particles.
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Figure 2.4. Immunofluorescence microscopy and Immuno-EM analysis of cells
expressing AldoPTS2eYFP. (A) Wide-field immunofluorescence microscopy of live 2913-AldoPTS2eYFP and AnTat1.1-AldoPTS2eYFP cells in SDM-79θ and SDM-79. Scale
bars represent 5 μm. (B) Immuno-EM analysis of 29-13-AldoPTS2eYFP and AnTat1.1-
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AldoPTS2eYFP stained with antibodies against eYFP. Scale bars represent 500 nm. (C)
Box plot quantification of number of gold particles per glycosome. ns: not significant. ***:
p < 0.001.

Extracellular glucose affects glycosome structure.

We next used transmission

electron microscopy (TEM) to resolve the number, size and morphology of the organelles
between the different cell lines grown in SDM-79 and SDM-79θ (Fig. 2.5A). Under the
staining conditions we used, glycosomes appear as electron-dense organelles. In both
cell lines the average size of glycosomes was larger in SDM-79θ as opposed to SDM-79
with 29-13 glycosomes being 1.9x larger and AnTat1.1 glycosomes being 1.24x larger
(Fig. 2.5B). Interestingly, the glycosome area had higher variance in AnTat1.1 (54.3% in
SDM-79 and 40.5% in SDM-79θ) cells than 29-13 (38.6% in SDM-79 and 35.8% in SDM79θ) in both medias. Similarly, there were more glycosomes per 100 nm2 in SDM-79θ
(Fig 2.5C). In 29-13 cells, glycosomes took up 1.5% of the cell volume in SDM-79 and
4% in SDM-79θ. A similar pattern was observed in AnTat1.1s where glycosomes
comprised 2.6% and 5% of the cell area in SDM-79 and SDM-79θ, respectively (Fig 2.5D).
We also observed a striking difference in the morphology of glycosomes between cell
lines. In 29-13, glycosomes were almost exclusively spherical in size whereas AnTat1.1
cells harbored many elongated structures resembling dividing glycosomes.

Glucose availability induces mitochondrial morphology changes in AnTat1.1 strain
parasites
In addition to these differences in glycosome morphology, we observed that the
mitochondrial morphology in AnTat1.1 cells changed with media conditions. (Fig 2.5E).
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When cultured in SDM-79θ, the morphology of the mitochondria of 29-13 cells does not
change relative to SDM-79. In contrast, AnTat1.1 cells cultured in SDM-79 exhibited a
larger, more electron dense mitochondrion as opposed to those cultured in SDM-79θ.
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Figure 2.5: Transmission EM analysis of ultrastructural changes in the presence of
glucose. (A) TEM micrograph of cells grown in SDM-79 or SDM-79θ continuously for at
least one month. Glycosomes are indicated by white arrows. Scale bar represents 500
nm. “m” denotes mitochondria. Asterisks denote dividing glycosomes. (B) Dot plot of
glycosome area in the presence and absence of glucose. ns: not significant. ***: p <
0.001. (C) Bar graph of average number of glycosomes per 100 μm2 cell area. (D) Bar
graph of average cell area occupied by glycosomes. (E) TEM images with mitochondria
highlighted in blue.

Glucose availability influences transcriptome expression. Due to the polycistronic
nature of kinetoplastid transcription, most regulation of gene expression occurs posttranscriptionally (42–44). To determine if glucose availability affects transcript abundance
in 29-13 and AnTat1.1 cells, we performed RNAseq on parasites adapted to each media.
For 29-13 cells, 5474 transcripts with a false discovery rate below 0.05 were identified by
RNAseq and 284 (5.1%) of those genes were up or down-regulated more than 2-fold.
AnTat1.1 cells exhibited a more dynamic response with 713 of 5573 (12.8%) total
transcripts being differentially expressed.

According to KEGG analysis, 58 of the

differentially expressed transcripts in AnTat1.1 cells were involved in purine metabolism.
Only 16 transcripts were differentially expressed in 29-13 cells (Table 2.2). Many of these
transcripts are genes related to expression site-associated gene 4 (GRESAG4). We
observed that both AnTat1.1 and 29-13 parasites grown in SDM-79θ have transcripts
enriched for glycosome related cellular components, as well as transporter activity and
metabolic processes (Table 2.3). Enriched transcripts associated with glycosome cell
component GO-term are summarized in Table 2.4. In both cell lines, glycerol kinase and
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hexokinase transcripts were differentially expressed; however, in AnTat1.1 cells many
more glycosome-associated transcripts are enriched including G6P isomerase, PEPCK,
and proteins associated with purine salvage and amino acid metabolism.
2913 differentially regulated purine metabolism

Gene ID

Product Description

AnTat1.1 differentially regulated purine metabolism
Media
Enriched

Gene ID

Product Description

Media
Enriched

Tb05.5K5.10
Tb05.5K5.180
Tb05.5K5.190
Tb11.v5.0281

conserved hypothetical protein, conserved (fragment)
receptor-type adenylate cyclase GRESAG 4, putative
receptor-type adenylate cyclase GRESAG 4, putative
receptor-type adenylate cyclase GRESAG 4, putative

SDM-79θ
SDM-79θ
SDM-79θ
SDM-79θ

Tb05.5K5.180
Tb05.5K5.190
Tb05.5K5.200
Tb09.v4.0009

receptor-type adenylate cyclase GRESAG 4, putative
receptor-type adenylate cyclase GRESAG 4, putative
guanine deaminase, putative
receptor-type adenylate cyclase, putative

SDM-79
SDM-79
SDM-79
SDM-79

Tb11.v5.0576
Tb11.v5.0615
Tb11.v5.1016
Tb927.10.15370

receptor-type adenylate cyclase GRESAG 4, putative
hypothetical protein, conserved
receptor-type adenylate cyclase GRESAG 4 (pseudogene), putative
DNA-directed RNA polymerases I and III subunit RPAC1, putative

SDM-79θ
SDM-79
SDM-79
SDM-79

Tb11.v5.0281
Tb11.v5.0409
Tb11.v5.0431
Tb11.v5.0576

receptor-type adenylate cyclase GRESAG 4, putative
guanine deaminase, putative
receptor-type adenylate cyclase GRESAG 4, putative
receptor-type adenylate cyclase GRESAG 4, putative

SDM-79θ
SDM-79
SDM-79
SDM-79θ

Tb927.11.1480
Tb927.11.1490
Tb927.11.17040
Tb927.3.2960

receptor-type adenylate cyclase GRESAG 4, putative
receptor-type adenylate cyclase GRESAG 4, putative (fragment)
procyclic-enriched flagellar receptor adenylate cyclase 1
inosine-adenosine-guanosine-nucleosidehydrolase

SDM-79
SDM-79
SDM-79θ
SDM-79θ

Tb11.v5.0605
Tb11.v5.0830
Tb11.v5.0865
Tb11.v5.1015

pyruvate kinase 1, putative
receptor-type adenylate cyclase GRESAG 4, putative
receptor-type adenylate cyclase GRESAG 4, putative
expression site-associated gene 4 (ESAG4) protein, putative

SDM-79
SDM-79
SDM-79
SDM-79θ

Tb927.5.330
Tb927.5.4540
Tb927.7.7470
Tb927.9.15660

receptor-type adenylate cyclase GRESAG 4, putative
receptor-type adenylate cyclase GRESAG 4, putative
procyclic-enriched flagellar receptor adenylate cyclase 3
procyclic-enriched flagellar receptor adenylate cyclase 6

SDM-79θ
SDM-79θ
SDM-79θ
SDM-79

Tb11.v5.1058
Tb927.1.540
Tb927.10.11700
Tb927.10.14140

DNA polymerase kappa, putative
DNA-directed RNA polymerase III, putative
guanylate kinase, putative
pyruvate kinase 1

SDM-79
SDM-79
SDM-79
SDM-79

Tb927.10.2430
Tb927.10.9990
Tb927.11.12820
Tb927.11.13740

receptor-type adenylate cyclase GRESAG 4, putative
non-canonical purine NTP pyrophosphatase, RdgB/HAM1 family, putative
ribonucleoside-diphosphate reductase small chain
procyclic-enriched flagellar receptor adenylate cyclase 5

SDM-79
SDM-79
SDM-79θ
SDM-79

Tb927.11.140
Tb927.11.1480
Tb927.11.1490
Tb927.11.150

expression site-associated gene 4 (ESAG4) protein, putative
receptor-type adenylate cyclase GRESAG 4, putative
receptor-type adenylate cyclase GRESAG 4, putative (fragment)
receptor-type adenylate cyclase GRESAG 4, putative

SDM-79θ
SDM-79
SDM-79
SDM-79θ

Tb927.11.17040
Tb927.11.18690
Tb927.11.5940
Tb927.3.2960

procyclic-enriched flagellar receptor adenylate cyclase 1
expression site-associated gene 4 (ESAG4) protein, putative
receptor-type adenylate cyclase GRESAG 4, putative
inosine-adenosine-guanosine-nucleosidehydrolase

SDM-79
SDM-79
SDM-79
SDM-79θ

Tb927.3.5100
Tb927.4.4410
Tb927.4.4430
Tb927.4.4440

tfiih basal transcription factor complex helicase xpb subunit
adenylyl cyclase
adenylyl cyclase
adenylyl cyclase

SDM-79
SDM-79
SDM-79
SDM-79

Tb927.4.4450
Tb927.4.4470
Tb927.4.4660
Tb927.5.330

adenylyl cyclase
adenylyl cyclase
Protein of unknown function DUF84, putative
receptor-type adenylate cyclase GRESAG 4, putative

SDM-79
SDM-79
SDM-79
SDM-79θ

Tb927.5.4310
Tb927.5.4540
Tb927.5.4560
Tb927.5.960

GTP-binding protein, putative
receptor-type adenylate cyclase GRESAG 4, putative
guanine deaminase, putative
atpase family aaa domain-containing protein 1

SDM-79
SDM-79
SDM-79
SDM-79

Tb927.6.170
Tb927.6.180
Tb927.6.2300
Tb927.6.2360

receptor-type adenylate cyclase GRESAG 4, putative
receptor-type adenylate cyclase GRESAG 4, putative
adenosine kinase, putative
adenosine kinase, putative

SDM-79
SDM-79
SDM-79
SDM-79

Tb927.6.280
Tb927.6.300
Tb927.6.310
Tb927.6.3210

receptor-type adenylate cyclase GRESAG 4, putative
receptor-type adenylate cyclase GRESAG 4, putative
receptor-type adenylate cyclase GRESAG 4, putative
Adenylate kinase, nuclear

SDM-79
SDM-79
SDM-79
SDM-79

Tb927.6.330
Tb927.6.760
Tb927.6.780
Tb927.6.790

receptor-type adenylate cyclase GRESAG
receptor-type adenylate cyclase GRESAG
receptor-type adenylate cyclase GRESAG
receptor-type adenylate cyclase GRESAG

4,
4,
4,
4,

putative
putative
putative
putative

SDM-79
SDM-79
SDM-79
SDM-79

Tb927.6.800
Tb927.7.4570
Tb927.7.6060
Tb927.7.7520
Tb927.7.7530

receptor-type adenylate cyclase GRESAG
inosine-guanine nucleoside hydrolase
receptor-type adenylate cyclase GRESAG
receptor-type adenylate cyclase GRESAG
receptor-type adenylate cyclase GRESAG

4, putative
4, putative
4, putative
4, putative

SDM-79
SDM-79
SDM-79
SDM-79
SDM-79

Tb927.8.7900

receptor-type adenylate cyclase GRESAG 4, putative

SDM-79

Table 2.2. Differentially expressed transcripts associated with purine metabolism.
Differentially expressed transcripts in 29-13 and AnTat1.1 cells in SDM-79 vs SDM-79θ
were analyzed by KEGG analysis using TriTrypDB. Differentially expressed transcripts
associated with purine metabolism shown.
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Table 2.3. GO-term enrichment of transcripts from RNAseq.

29-13 and AnTat1.1

strain cells were maintained in either SDM-79θ or SDM-79 and total transcriptome was
determined by RNAseq. GO-term enrichment of transcripts with a FDR < 0.05 and FC ≥
2 was performed using TriTrypDB. Values are shown for number of genes associated
with the GO-term (genes in the bkgd), the number of genes found to be significantly
enriched, the percentage of background genes enriched, and associated P-value and
Benjamini factors.
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2913 Glycosome Transcript Enrichment
Gene ID
Tb927.1.3830
Tb927.2.4210
Tb927.3.2960
Tb927.5.300
Tb927.6.4280
Tb927.6.4300
Tb927.8.2450
Tb927.9.6090
Tb927.9.6100
Tb927.9.6250
Tb927.9.11600
Tb927.9.12550
Tb927.9.12570
Tb927.10.2010
Tb927.10.2020

Table 2.4.

AnTat1.1 Glycosome Transcript Enrichment

Product Description
glucose-6-phosphate isomerase, glycosomal
Phosphoenolpyruvate carboxykinase [ATP], glycosomal
inosine-adenosine-guanosine-nucleosidehydrolase
thymine-7-hydroxylase, putative
glyceraldehyde 3-phosphate dehydrogenase, glycosomal
glyceraldehyde 3-phosphate dehydrogenase, glycosomal
5'-AMP-activated protein kinase subunit beta
PTP1-interacting protein, 39 kDa
PTP1-interacting protein, 39 kDa
arginine kinase
glycosomal membrane protein
glycerol kinase, glycosomal
glycerol kinase, glycosomal
hexokinase
hexokinase

Gene ID
Tb927.3.2960
Tb927.9.11600
Tb927.9.12550
Tb927.9.12570
Tb927.9.12590
Tb927.9.12610
Tb927.9.12630
Tb927.10.2010
Tb927.10.2020
Tb927.11.900

Product Description
inosine-adenosine-guanosine-nucleosidehydrolase
glycosomal membrane protein
glycerol kinase, glycosomal
glycerol kinase, glycosomal
glycerol kinase, glycosomal
glycerol kinase, glycosomal
glycerol kinase, glycosomal
hexokinase
hexokinase
isocitrate dehydrogenase, putative

SDM-79θ transcript enrichment associated with glycosome cell

compartment GO-term. Transcripts associated with glycosome cell component that are
enriched in SDM-79θ. Differentially expressed transcripts were analyzed by GO-term
enrichment using TriTrypDB.

Because AnTat1.1 strain cells displayed a more pronounced response to glucose, we
analyzed the transcriptome of AnTat1.1 cells immediately following the switch from SDM79θ to SDM-79 and from SDM-79 to SDM-79θ for cells that were cultured for longer than
a month in SDM-79 to be allowed to adapt to the presence of glucose (Fig. 2.6). When
introduced to glucose, AnTat1.1 strain parasites differentially regulated 583 transcripts out
of 5835 (10.0%) with 318 increasing in abundance and 265 decreasing in abundance.
Conversely, when AnTat1.1 cells were transitioned from SDM-79 to SDM-79θ, only 120
genes out of 4281 (2.8%) were differentially expressed with 74 increased in abundance
and 46 decreased in abundance.

GO term analysis is summarized in Table 2.5.

Transcripts associated with glycosome cell compartment were downregulated when
AnTat1.1 cells were transitioned from SDM-79θ to SDM-79, and upregulated when
transitioned from SDM-79 to SDM-79θ. In both conditions, glycerol kinase and isocitrate
dehydrogenase were differentially regulated; however, in the transition from SDM-79θ to
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SDM-79, more genes were differentially regulated including G6P isomerase, hexokinase,
and FBP (Table 2.6).

Figure 2.6. Schematic of cell culture for AnTat1.1 response to media change. Cells
were passaged from SDM-79θ to SDM-79 and cultures were maintained in either SDM79θ or SDM-79 for at least one month of continuous culture. Cells were seeded at 2x105
cells/ml and harvested at mid-long 2x106 cells/ml.
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Table 2.5. GO-term enrichment of AnTat1.1 transcripts immediately after passage
from SDM-79θ to SDM-79 or from SDM-79 to SDM-79θ. Cells were adapted to SDM79θ or SDM-79, passed into SDM-79 or SDM-79θ, respectively, and grown to a density of
2x106 cells / ml, harvested and RNA was isolated and prepared for RNAseq. GO-term
enrichment of transcripts with a FDR < 0.05 and FC ≥ 2 was performed using TriTrypDB.
Values shown for number of genes associated with the GO-term (genes in the bkgd), the
number of genes found to be significantly enriched, the percentage of background genes
enriched, and associated P-value and Benjamini factors.
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Table 2.6.

AnTat1.1 short-term differentially regulated glycosome-associated

transcripts. Transcripts associated with glycosome cell component that are enriched in
either AnTat1.1 cells passaged from SDM-79θ.

Transcripts shown are more highly

expressed in SDM-79θ. Differentially expressed transcripts were analyzed by GO-term
enrichment using TriTrypDB.

AnTat1.1 short term response and long term response cluster together more closely
than long term response of 29-13. Transcripts that were detected in all conditions with
a FDR < 0.05 were plotted on a hierarchically clustered heatmap (Fig. 2.7A). The longterm and short-term response of AnTat1.1 parasites cluster together more closely than
the long-term response of 29-13 strain parasites, indicating that continuous culture of 2913 cells has resulted in a divergent response to glucose availability.

Comparison of 29-13 and AnTat1.1 strain parasites grown and adapted in either SDM-79
or SDM-79θ shows that gene expression varies between strains. Pair-wise comparisons
of 29-13 and AnTat1.1 cells grown in the same media show that many genes are
differentially expressed between parasite strains. Volcano plots depict the log fold change
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value plotted with the p-value for differentially expressed transcripts (Fig. 2.7B). In SDM79, 451 out of 4,436 (10.2%) transcripts are differentially expressed between 29-13 and
AnTat1.1 strains, while in SDM-79θ, there are 666 out of 6,034 total transcripts (11.0%)
differentially expressed transcripts.

Figure 2.7: Global transcriptome is impacted by glucose availability. (A) Transcripts
with a FDR < 0.05 in all conditions were hierarchically clustered comparing differences in
29-13 and AnTat1.1 response to glucose either steady state or short term-response. (B)
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Volcano plots of pair-wise comparisons plotting log fold change vs p-value of differentially
expressed genes between shown in panel A.

Protein expression is influenced by glucose. To analyze total protein enrichment in
SDM-79θ vs SDM-79, cells cultured in these medias were subjected to mass spectrometry
analysis.

Differentially expressed peptides (false discovery rate below 0.05) were

analyzed using TriTrypDB to determine GO-term enrichment (Table 2.7). Proteomic
analysis revealed that 53 out of 155 total proteins (34.2%) in 29-13 cells with were
differentially regulated in response to glucose with 29 being upregulated in SDM-79 and
24 upregulated in SDM-79θ. AnTat1.1 parasites had 70 of 214 total proteins (32.7%)
differentially expressed, with 49 more abundant in SDM-79 and 21 more abundant in
SDM-79θ. GO term analysis of identified proteins showed enrichment for glycosomal
proteins involved in glycolysis, amino acid metabolism and purine salvage in SDM-79θ,
similar to RNAseq analysis (Table 2.8).
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Table 2.7. GO-term enrichment of detected peptides from whole cell lysates. Cells
were maintained in either SDM-79θ or SDM-79 and analyzed by mass spectrometry.
Peptides detected with a FDR < 0.05 were analyzed using TriTrypDB for GO-term
enrichment. Values shown for number of genes associated with the GO-term (genes in
the bkgd), the number of genes found to be significantly enriched, the percentage of
background genes enriched, and associated P-value and Benjamini values.
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2913 Glycosome Protein Enrichment
Gene ID
Tb927.3.2960
Tb927.6.4280
Tb927.7.7500
Tb927.8.3530
Tb927.9.6090
Tb927.9.11600
Tb927.10.2010
Tb927.11.900
Tb927.11.5520

Table 2.8.

AnTat1.1 Glycosome Protein Enrichment

Product Description
inosine-adenosine-guanosine-nucleosidehydrolase
glyceraldehyde 3-phosphate dehydrogenase, glycosomal
thymine-7-hydroxylase, putative
glycerol-3-phosphate dehydrogenase [NAD+], glycosomal
PTP1-interacting protein, 39 kDa
glycosomal membrane protein
hexokinase
isocitrate dehydrogenase, putative
triosephosphate isomerase

Gene ID
Tb927.1.3830
Tb927.3.2960
Tb927.7.7500
Tb927.9.11600
Tb927.9.12110
Tb927.9.12610
Tb927.10.2010
Tb927.10.6150
Tb927.11.900

Product Description
glucose-6-phosphate isomerase, glycosomal
inosine-adenosine-guanosine-nucleosidehydrolase
thymine-7-hydroxylase, putative
glycosomal membrane protein
6-phosphogluconate dehydrogenase, decarboxylating
glycerol kinase, glycosomal
hexokinase
neurobeachin/beige protein, putative
isocitrate dehydrogenase, putative

SDM-79θ protein enrichment associated with glycosome cell

compartment GO-term. Proteins associated with glycosome cell component that are
enriched in SDM-79θ.
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Discussion

Trypanosoma brucei is transmitted between tsetse fly insect vector and mammalian host.
During this life cycle, the parasites differentiate to adapt to their changing environments.
In the tsetse fly midgut, PF cells do not have access to glucose except for immediately
following a bloodmeal (1). Although in nature, glucose is not available to PF parasites,
lab-adapted strains have been cultured in glucose-rich media such as SDM-79. Further
complicating studies on T. brucei is that most studies use lab-adapted strains that cannot
complete the life cycle. Because of these issues, it is important to understand how glucose
availability and strain variation impact studies performed in PF parasites.

In previous studies, the culture medias SDM-80 (4, 8, 38, 39) or conditioned SDM-79
(SDM-79 that uses a pre-culture of cells to deplete glucose levels) (40, 41) were used to
mimic low glucose conditions. In earlier work using flow cytometry to follow glycosomally
targeted eYFP, we found that cells grown in SDM-79 were brighter than those grown in
SDM-80 (8). SDM-80 is a low (1 mM) glucose medium derived from SDM-79. However
other components vary, making direct comparisons between the two conditions difficult
(4). Additionally, because SDM-80 includes fetal bovine serum, which contains glucose,
it is not glucose-free. Conditioned SDM-79 uses a method of pre-culturing cells in the
media to deplete glucose. This treatment also results in the depletion of other nutrients
and accumulation of excreted metabolites. Recently, our lab has begun to use a modified
SDM-79, called SDM-79θ. This medium contains dialyzed FBS and no added glucose.
In this work, we use SDM-79θ (containing 5 μM glucose) to resolve the effects of
availability on T. brucei gene expression (45). The use of this more defined media
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provides greater confidence that the changes we observe are due to differences in glucose
levels and not a consequence of other environment differences.

Most studies on T. brucei metabolism have been performed using monomorphic cell lines
such as 29-13 derived from the 427 background (4, 9, 20, 25, 39, 46, 47). The use of
these cell lines provides multiple advantages such as easier genetic manipulation for
inducible expression and a well annotated genome. Because the 29-13 strain parasites
have been cultured for decades, they have lost the ability to differentiate between PF and
BSF, and lab-adaptation may have resulted in the loss of processes essential for survival
in the insect vector. Because of this, we are using the pleomorphic strain AnTat1.1
isolated from mice and differentiated to PF in vitro using glucose depletion as a
differentiation cue (15). In addition to the pleomorphic nature of the AnTat1.1 strain, these
cells have been maintained in SDM-79θ to better simulate the glucose-deplete
environment of the tsetse fly midgut.

Removal of glucose from the culture medium of 29-13 strain parasites by resulted in
slowed growth rate. The doubling time was 15 h in SDM-79θ and 13.5 h in SDM-79. In
contrast, AnTat1.1 parasites had a doubling time of 33.6 h in SDM-79 and 16 h in SDM79θ. Interestingly, although 29-13s and AnTat1.1s responded differently to glucose in
growth rate, glycosomal protein expression changed in a similar manner between the
strains. In both cell lines, expression of an ectopic glycosomally-targeted fluorescent
protein, AldoPTS2eYFP, was increased in high glucose.

Using flow cytometry, the

intensity of the AldoPTS2eYFP increased over a period of several days after passage into
SDM-79. In 29-13 cells, the measured fluorescence intensity did not differ significantly
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between SDM-79θ and SDM-79 and maintained a narrow peak, while the initial broad
range of fluorescence intensities found in AnTat1.1 cells cultured in SDM-79θ increased
upon passage to SDM-79 and displayed lower cell-to-cell variability. The greater variation
in fluorescence intensity of cells cultured in SDM-79θ suggested that there is greater
interparasite heterogeneity with respect to glycosome composition.

To resolve possible intraparasite organelle heterogeneity, we utilized immuno-EM with
antibodies against AldoPTS2eYFP. In both 29-13 and AnTat1.1 cells cultured in SDM79θ, we observed that there were many organelles that did not contain any detectable
gold particles; however, in cells cultured in SDM-79, the total number of gold particles was
dramatically higher with many organelles containing 5 or more gold particles. Based on
these data, it is important to note that although fluorescent markers fused to a peroxisomal
targeting sequence have long been used as organelle markers, it might not be found in
every organelle.

Ultrastructural organelle analysis using TEM of 29-13 and AnTat1.1 parasites revealed
that in both strains, glycosomes are larger in cells cultured in SDM-79θ and that there are
more organelles per 100 μm2 of cell area.

Interestingly, we observed that the

mitochondrion of AnTat1.1 cells becomes much larger and electron dense in SDM-79, a
morphological change that we do not observe in 29-13.

In addition to changes in organelle composition and morphology, we wanted to determine
how extracellular glucose levels influenced RNA and protein levels using RNAseq and
mass spectrometry (MS) in 29-13 and AnTat1.1 parasites grown in high and low glucose.
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In both RNAseq and MS analysis, we observed enrichment for the GO-term
encompassing glycosome cell components. While both 29-13 and AnTat1.1 cells had
significant enrichment for glycosome cell components in SDM-79θ, many more transcripts
were differentially regulated in AnTat1.1 cells relative to 29-13s. In both cases, glycerol
kinase,

hexokinase,

thymine-7-hydroxylyase,

and

inosine-adenosine-guanosine-

nucleosidehydrolase were enriched in SDM-79θ, suggesting that many glycosomal
metabolic pathways are up-regulated in the absence of readily available glucose.
Interestingly, KEGG analysis of differentially expressed metabolic pathways revealed
enrichment for transcripts associated with purine metabolism, with many of the transcripts
being associated with GRESAG4 (genes related to expression site associated gene 4,
ESAG4) and adenylyl cyclase. These gene products may function as surface receptors
that are responsible for cellular response to environmental conditions and we speculate a
role in nutrient sensing (48, 49).

Because AnTat1.1 strain parasites display a more pronounced reaction to changes in
glucose availability, we analyzed the short-term response to changes in media. Cells were
switched from SDM-79 to SDM-79θ or from SDM-79θ to SDM-79 and were analyzed by
RNAseq once cell density reached mid-log phase. Comparison of the short- and longterm differentially expressed transcripts revealed that when AnTat1.1 cells are transitioned
to glucose rich media, EP procyclin is down-regulated initially, but increases expression
as cells adapt to SDM-79. In contrast, GPEET procyclin is expressed at very high levels
in AnTat1.1 cells maintained in SDM-79θ; however expression decreases in response to
addition of glucose and is very low in AnTat1.1 and in 29-13 cells cultured in SDM-79.
Procyclic form parasites that have been differentiated in vitro in other studies have
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displayed a progression of initial GPEET expression, which is characteristic of early
procyclic cells, which is replaced by EP procyclin, characteristic of late procyclic form
parasites (50, 51). Interestingly, although glucose appears to influence expression of
GPEET procyclin, inhibition of glycolysis does not alter GPEET expression, suggesting
that sensing of glucose availability is involved in progression of life cycle stage rather than
glycolytic flux (51).

Comparison of the transcriptome of 29-13 and AnTat1.1 cells cultured in the same media
revealed significant strain variation in gene expression. In cells cultured in SDM-79,
10.2% of detected transcripts were significantly different between 29-13 and AnTat1.1
cells, with a significant enrichment for cytoskeletal components including alpha and beta
tubulin. Similarly, 11.0% of detected transcripts were differentially expressed in SDM-79θ
displaying significant enrichment for differentially expressed cell surface proteins such as
GPEET and EP.

In both conditions, transcripts associated with glycosomes were

differentially expressed. This variation in transcriptome between 29-13 and AnTat1.1
parasites highlights the importance of considering strain variation between studies.
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Summary
These results suggest that both strain variation and culture conditions are important
considerations when applying results between studies and to cells found in nature. Prior
studies have used SDM-80 culture medium to better mimic conditions found in the tsetse
fly midgut, however this medium is not glucose free due to the glucose content of the
serum that is used. Additionally, it is important to understand how different strains of T.
brucei vary relative to each other. Although an increasing number of studies use the
pleomorphic AnTat strains, this is an essential consideration in using the lab-adapted
strains.
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TbPex13.2 is an accessory peroxin that functions in the import of PTS2 proteins and
localizes to subdomains of the glycosome
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Abstract
Kinetoplastid parasites including Trypanosoma brucei, Trypanosoma cruzi and
Leishmania harbor unique organelles known as glycosomes, which are evolutionarily
related to peroxisomes. Glycosome/peroxisome biogenesis is mediated by proteins
called peroxins that facilitate organelle formation, proliferation and degradation, and
import of proteins housed therein. Import of matrix proteins occurs via one of two
pathways that are dictated by their peroxisome targeting sequence (PTS). In PTS1
import, a C-terminal tripeptide sequence, most commonly SKL, is recognized by the
soluble receptor Pex5. In PTS2 import, a less conserved N-terminal sequence is
recognized by Pex7. The soluble receptors deliver their cargo to the import channel
consisting minimally of Pex13 and Pex14.

While much of the import process is

conserved, kinetoplastids are the only organisms to have two Pex13s, TbPex13.1 and
TbPex13.2. In previous studies, GFP-tagged TbPex13.1 localized to glycosomes and
silencing either protein in the stage of the parasite that lives in the mammalian bloodstream
impaired glycosome protein import and slowed parasite growth. While these findings
suggest Pex13s are involved in protein import, the mechanisms by which they function is
unknown and it is unclear why kinetoplastids would require two Pex13s. In this work, we
demonstrate that TbPex13.2 is associated with the glycosome membrane with its Nterminus facing the cytoplasm. Super-resolution microscopy reveals that TbPex13.2
localizes to a few (1-3) foci per glycosome. Transmission electron microscopy (TEM)
revealed that glycosome morphology was not altered in TbPex13.2 silenced cells, while
biochemical analysis indicated that organelle density was altered. The import of PTS2
harboring proteins was disrupted in TbPex13.2-deficient cells when induced for RNAi.
These data suggest a role for TbPex13.2 in PTS2 mediated protein import to glycosomes.
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INTRODUCTION

The family Kinetoplastea includes a number of medically relevant parasites including
Trypanosoma brucei, Trypanosoma cruzi and several species of Leishmania that cause
human African trypanosomiasis, Chagas disease, and several forms of leishmaniasis.
Treatments for these diseases are expensive, toxic and difficult to administer.
Additionally, the growing resistance to current therapies necessitates the need for the
identification of new drug targets.

All kinetoplastids have unique membrane-bounded microbodies called glycosomes that
are evolutionarily related to peroxisomes of higher eukaryotes (1, 2). Peroxisomes and
glycosomes lack DNA and import most matrix proteins post-translationally (2).
Glycosomes are unique in that they harbor many of the enzymes in the glycolytic pathway,
which are cytosolic in higher eukaryotes (3–5). The essential nature of these organelles
makes them a good drug target and small molecules that interrupt protein import into
glycosomes were lethal to T. brucei (6).

Peroxisome biogenesis is regulated by proteins called peroxins (PEXs) that govern
organelle formation, proliferation, and degradation as well as protein import (2, 3, 7).
Import of proteins into peroxisomes involves binding of soluble receptor proteins, either
Pex5 or Pex7, to a targeting sequence in the cargo protein (8, 9). Pex5 binds to a Cterminal tripeptide with the consensus sequence of SKL called a peroxisome targeting
sequence 1 (PTS1) while Pex7 binds to a less conserved N-terminal sequence termed
PTS2 (2, 10, 11). The receptor-cargo complex then docks at the peroxisome membrane
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through interactions with the glycosome membrane proteins Pex13 and Pex14, which
make up the import channel (12). After import, the receptors are recycled for transport
back to the cytosol via a ubiquitination process involving Pex2, 10, and 12 (13).

While much of the import pathway is conserved, kinetoplastids are unique in that they
have two Pex13s, which have been designated Pex13.1 and Pex13.2 (14, 15). These
proteins share low sequence identity with each other or with other Pex13s; however,
maintain domain similarity. In previous studies, TbPex13.1, which was the first identified,
localized to glycosomes and mammalian bloodstream form (BSF) and insect stage,
procyclic form (PF), TbPex13.1-deficient parasites exhibited defects in glycosome protein
import and slowed growth rates (15). Later, iterative database searches resulted in the
identification of TbPex13.2 (14).

Silencing of TbPex13.2 via RNA interference in BSF

parasites resulted in mislocalization of TbPex14 and Tbaldolase and a defect in growth
rate.

Previous to our work, TbPex13.2 RNAi cells lines could not be established in PF

parasites (14).

In pursuit of understanding function, we confirmed that native TbPex13.2 is an integral
glycosome membrane protein and demonstrated that its N-terminus is on the cytoplasmic
side of the membrane. Super-resolution microscopy revealed that TbPex13.2 localization
is restricted to a few foci (1-3)/organelle and TbPex13.2-deficient PF parasites exhibit a
defect in PTS2 import, suggesting that it may serve as a co-receptor in PTS2 import.
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MATERIALS AND METHODS

Cell culture and transfection of T. brucei: Procyclic form (PF) 29-13 and bloodstream
form (BSF) 90-13 expressing T7 polymerase and tetracycline (tet) repressor (16) were
maintained in SDM79 (or the minimal glucose variant SDM79θ containing 5 μM glucose)
(17) and HMI-9 culture medium (18), respectively. Expression vectors for epitope-tagged
proteins were generated by cloning the open reading frame of TbPex13.2 into the pXS2
(PF) vector or pXS6 (BSF) vectors possessing either a blasticidin resistance or puromycin
resistance gene (19). For transfection, 20 μg plasmid DNA was linearized (pXS2, pXS6:
MluI; pZJM: NotI) and electroporated in 4 mm cuvettes (BioRad GenePulser Xcell;
exponential, 1.5kV, 25μF). Twenty-four hours after electroporation, culture media was
supplemented with appropriate drug for selection: 15 μg/ml G418; 50 μg/ml hygromycin;
2.5 μg/ml phleomycin; 1 μg/ml puromycin; 10 μg/ml blasticidin. RNAi cell lines were
generated by nucleotides

41-441 of TbPex13.2

into the inducible pZJM vector

possessing dual opposing T7 promoters and a phleomycin resistance marker (20).
Usually we grow RNAi cell lines in tet-free media to reduce leaky expression from RNAi
plasmids. However, this was not required for these cell lines.

TbPex13.2 antibody production: Polyclonal guinea pig antisera was generated against
recombinant TbPex13.2 (Thermo Scientific). Amino acids 2-150 of TbPex13.2 fused to
an N-terminal His6 tag was expressed using the pQE30 expression system (Qiagen) and
purified using a Ni-NTA column under denaturing conditions using 8M urea as described
(21).
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Growth curves: Cells possessing the RNAi inducible pZJM:TbPex13.2 vector were
seeded at 105 cells/mL in SDM79 (PF) or 5x104 cells/mL HMI-9 (BSF) and induced with 1
μg/ml doxycycline. PF cells were allowed to grow to a density of 5x106 cells/mL prior to
passing back to 1x105. BSF cells were allowed to grow to a density of 1x106 cells/mL prior
to passing back to 5x104 cells/mL. Culture density was monitored by flow cytometry at 24
h intervals using an Accuri C6 flow cytometer (BD Biosciences).

Sucrose gradient fractionation and western blot:

Large-scale sucrose gradient

fractionation was carried out as described previously (22). Small-scale fractionations for
TbPex13.2 silencing were separated as described previously (22) with the following
modifications:

the post-nuclear lysate was separated on a 13 mL 20%-40% linear

Optiprep gradient at 170,000g for 19 h in a Beckman SW-40Ti rotor at 4oC (acceleration
9 and deceleration coast), 500 μl fractions were taken from the top of the gradient and the
protein concentration was determined by BCA assay (ThermoFisher). Protein from each
fraction (2.5 μg) was separated by SDS-PAGE and analyzed by western blotting with
antibodies against the glycosomal proteins: Tbaldolase (1:20,000), TbPex13.1 (1:10,000),
TbPex13.2 (1:10,000), TbPex11 (1:4,000) provided by Dr. Christine Clayton (Zentrum für
Molekulare Biologie der Universität Heidelberg, Germany) (23), TbPFK (1:10,000) and
TbFBP (1:10,000) provided by Dr. Paul Michels (University of Edinburgh, UK), and the ER
protein TbBiP (1:100,000) provided by Dr. Jay Bangs (University at Buffalo, Buffalo, NY)
(19).

Protease protection assays:

Protease protection assays were carried out using

modified protocol previously described (23). Cells (106) were harvested at 800g for 10
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min, washed once in PBS (150 mM NaCl, 1 mM KH2PO4, 5.6 mM Na2HPO4, pH 7.4), once
in STE buffer (250 mM sucrose, 25 mM Tris-HCl, pH7.4, 1 mM EDTA), and resuspended
in 98 μl ice cold STEN buffer (STE buffer supplemented with 150 mM NaCl) and 0.1 mM
phenylmethylsulfonyl fluoride (PMSF). Cells were permeabilized with 2 μl 1mg/mL
digitonin (final concentration of 0.02 mg/ml), vortexed for 5 seconds and incubated at room
temperature for 4 min. Following permeabilization, cells were centrifuged at 20,000g for
2 min and resuspended in 85 μl STEN buffer. Pellets were treated with either 10 μl water
or Triton X-100 (1% v/v final) and either 5 μl water or 2 mg/ml proteinase K. Reactions
were incubated on ice for 30 min and stopped by addition of 10% w/v trichloroacetic acid
(TCA). Precipitated proteins were centrifuged at 17,000g for 10 min and washed once
with acetone before being resuspended in cracking buffer (CB; 10% glycerol, 2% SDS,
2% β-mercaptoethanol, 100mM Tris, pH 6.8, 0.1% bromophenol blue) and boiled at
100oC. Proteins were then analyzed by SDS-PAGE and western blotting.

Membrane association assays: Membrane association assays were carried out as
previously described by (23).

For extraction of membrane proteins, 107 cells were

centrifuged at 800g for 10 min and resuspended in 300 μl of ice-cold low-salt buffer for 15
min (5 mM Tris-HCl pH 7.8, 1 mM EDTA, 0.1 mM PMSF, 4 μg/ml leupeptin). Cells were
then passed through a pipette tip 10x and centrifuged at 20,000g for 30 min at 4oC. The
insoluble pellet was resuspended in 300 μl high salt buffer (25 mM Tris-HCl pH7.8, 0.5 M
KCl, 1 mM EDTA, 0.1 mM PMSF, 4 μg/ml leupeptin) and incubated on ice for 15 min.
After incubation, samples were centrifuged again at 20,000g for 30 min at 4oC. The
insoluble pellet was resuspended in 300 μl 0.1 M Na2CO3 and incubated for 30 min on ice.
Samples were then centrifuged at 120,000g for 1h at 4oC with a 500 μl cushion of 0.1 M
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Na2CO3, 0.25 M sucrose in a Beckman TLA100.3 rotor.

Supernatant protein was

precipitated by 10% w/v TCA and washed once with acetone before being resuspended
in CB. Samples were then separated by SDS-PAGE and analyzed by western blot.

Live cell microscopy: Cells expressing either TbAldoPTS2eYFP or TbHKPTS2eYFP
(Fig. 6B) were washed once with PBS, mounted on a slide and visualized using a Zeiss
Axiovert 200M inverted fluorescence microscope with a 100x objective (N.A. 1.3). Images
analyzed using AxioVision software version 4.8.2.

Immunofluorescence microscopy: Cells were harvested (800g, 10 min), washed once
with PBS, fixed with 2% paraformaldehyde in PBS for 30 minutes at RT and allowed to
settle on slides for 30 min. Adhered cells were washed once with wash solution (0.1%
normal goat serum in PBS) and permeabilized with 0.5% Trition X-100 for 30 min.
Following permeabilization, cells were washed twice with wash solution and blocked with
10% normal goat serum (NGS) in PBS with 0.1% Triton X-100. Primary antibodies were
diluted in block solution (C-Myc, Thermo Fisher 9E10 1:500; TbAldolase 1:500; TbHK
1:500; TbFBP 1:1,000; TbPFK 1:500) and incubated with cells for 1 h. Following primary
antibody, slides were washed 3x with wash solution and incubated 1 h with secondary
antibody (goat anti-mouse Alexa fluor 488 1:1,000, goat anti-rabbit Alexa fluor 568 or
Alexa fluor 647 1:1,000; (Thermo fisher) in block. Wide field images were taken using a
Zeiss Axiovert 200M, 100x objective (N.A. 1.3), and analyzed using AxioVision software
version 4.8.2. Super-resolution images were obtained using a Leica SP8X microscope
equipped with HyD detector and 63x objective (N.A. 1.4).
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Electron microscopy processing and imaging: Cells were harvested (5x107, 800g 10
min), washed three times with PBS, and fixed (2% paraformaldehyde, 2.5%
glutaraldehyde in 100mM phosphate buffer pH 7.4). Cells were stored at 4oC for no longer
than 2 days before being processed as described previously (24).

Glycosome area

measurements were performed using FIJI (25). Area of visible glycosomes for 15 cells
was measured using the measure tool. To calculate the glycosome area as a percentage
of cell area, the area of glycosomes from each cell was summed and divided by the total
cell area visible.
Biochemical analysis of glycosome protein localization: Cells were seeded at 1x105
cells/ml and RNAi against TbPex13.2 was induced with 1 μg/ml doxycycline. After 4 days
of induction, cells were harvested (800g, 10 min) and washed once with PBS. Cells
(2x107) were lysed using 1 volume wet weight silicon carbide abrasive and breakage
confirmed by microscopy. Abrasive was removed by centrifugation (100g, 1 min) and
supernatant was transferred to a new tube, followed by removal of nuclei (1,000g, 15 min).
Supernatant was transferred to a new tube and the organelle rich fraction was separated
from the cytosolic fraction by centrifugation (17,000g, 15 min). Cytosolic proteins were
precipitated with 4 volumes of acetone, incubated on ice for 1 hour, and centrifuged at
17,000g for 10 min, 4oC. Pelleted organelle-rich fraction and cytosolic proteins were
separated by SDS-PAGE and proteins detected by western blotting with error calculated
from three replicates.
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RESULTS

TbPex13.2 is expressed in BSF and PF parasites.
Antibodies raised against recombinant TbPex13.2 detected a 28 kDa protein in PF and
BSF parasites, which was reduced upon induction of RNA interference (Fig. 3.1). These
antibodies sometimes detected a larger ~50 kDa protein. This larger band was not
reduced in TbPex13.2 RNAi cell lines, suggesting it was a non-specific, cross-reactive
protein. To confirm that this upper band was not a dimer of TbPex13.2, we treated lysates
with DTT (10 mM) and NEM (10 mM) to block free reactive thiols and prevent dimerization
post-lysis. Neither treatment affected the abundance of the 50 kDa species (Fig. S1).

Figure 3.1. Antibodies raised against recombinant TbPex13.2 recognize a 28 kDa
protein in PF and BSF parasites that is reduced upon induction of RNAi. PF and
BSF parasites harboring pZJM:Pex13.2 were grown for 4 days with and without
doxycycline to induce RNAi.

Lysates from 2x106 cells were probed with antisera

generated against rTbPex13.2 aa 2-150.

Tubulin was used as a loading control. *

indicates cross-reactive bands
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TbPex13.2 is an integral glycosomal membrane protein with its N-terminus exposed
to the cytosol
To confirm that TbPex13.2 was localized to glycosomes, we resolved organelles via
density gradients and analyzed fractions by western blotting. Under our conditions, the
ER is less dense than glycosomes and equilibrates at the top of the gradient. Consistent
with being a glycosome protein, TbPex13.2 was detected in fractions 14-20 that also
contained the glycosome protein aldolase (Fig. 3.2). In contrast, the ER protein, TbBiP,
was detected in fractions 20-32.

Figure 3.2. TbPex13.2 equilibrates with glycosome proteins in density
gradients. Post nuclear cell lysate was centrifuged through an Optiprep / sucrose
gradient and 1mL fractions were collected from the bottom of the gradient. Protein was
precipitated, separated by SDS-PAGE and analyzed by western blot with antibodies
against Tbaldolase, TbBiP, and TbPex13.2.

TbPex13.2 is predicted to have at least 2 transmembrane (TM) domains (14, 26). To
confirm that TbPex13.2 is an integral membrane protein, we sequentially extracted
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membrane-enriched fractions with low-salt, high-salt, and sodium carbonate (Fig. 3A).
The soluble glycosome matrix protein Tbaldolase was detected in the low and high-salt
supernatants, whereas TbPex13.2 was detected only in the pellet following sodium
carbonate extraction, as expected for an integral membrane protein. Orientation of the
protein in the membrane was determined by protease protection assays with cells
expressing TbPex13.2 fused to either an N-terminal myc epitope (mycTbPex13.2) or an
N-terminal mycBirA* tag (mycBirA*TbPex13.2). Treatment of cell lysate with proteinase
K (PK) in the absence of Triton X-100 resulted in loss of myc signal, indicating that the Nterminus of the protein was accessible by PK and exposed to the cytosol (Fig. 3B).
Tbaldolase is a matrix protein with a protease resistant core. Full-length Tbaldolase was
detected in PK treatment without detergent indicating that glycosome integrity is not
compromised during treatment. After treatment with PK and detergent, we observed a
smaller band as seen in previous studies documenting the protease-resistant nature of
Tbaldolase (27). These results suggest that the N-terminus of TbPex13.2 is on the
cytosolic side of the glycosome membrane. The C-terminus of TbPex13.2 was not able
to be tagged using an epitope tag.
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Figure 3.3. TbPex13.2 is an integral membrane protein with the N terminus
exposed to the cytosol. (A) Membrane protein extraction of whole cell membranes.
Cells (107) were sequentially extracted with low salt, high salt, and sodium carbonate.
Proteins were precipitated from supernatants (LS, HS, CS) and final pellet (CP),
separated by SDS-PAGE, transferred to nitrocellulose, and analyzed by western blotting
with antibodies against TbPex13.2 and aldolase. (B) Protease protection assay. Cells
were treated with Triton X-100, protease K, or Triton X-100 and protease K. Samples
were resolved by SDS-PAGE and analyzed by western blots with anti-myc antibodies.

TbPex13.2 is concentrated in punctate structures that are restricted to a subset of
glycosomes
Antibodies raised against recombinant TbPex13.2 do not work in immunofluorescence
assays (IFA). Because of this, we analyzed cell lines expressing TbPex13.2 fused to an
N-terminal myc tag (mycTbPex13.2) (Fig. 3.4 A, B). Anti-myc antibodies labeled punctate
structures that were distributed throughout the cell and exhibited limited overlap with the
glycosome marker Tbaldolase. We used Mander’s overlap coefficients (MOCs) to quantify
the extent to which TbPex13.2 co-localized with the glycosome marker aldolase and the
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ER marker TbBiP (Fig. 3.4 C, D) (28). MOC values range from 0 (no overlap) to 1
(complete overlap) (29). MOC for Tbaldolase and TbPex13.2 was 0.62 ± 0.16 suggesting
limited co-localization.

To better define the relationship between TbPex13.2 and

Tbaldolase staining, we calculated Mander’s M1 and M2 values, which reveal the extent
to which pixels in one channel overlap with the other. The M1 and M2 values were 0.49
± 0.20 and 0.91 ± 0.10, respectively. These numbers indicate that 49% of the signal in
channel 1 (Tbaldolase) overlaps with channel 2 (myc) and that 91% of the signal in
channel 2 (myc) overlaps with channel 1 (Tbaldolase).

These results suggest that

TbPex13.2 is limited to a portion of the glycosome area. MOC values for TbBiP and
TbPex13.2 was 0.17 ± 0.07, suggesting that these two proteins do not co-localize. In
agreement with the MOC, M1 and M2 values, we observed that mycTbPex13.2 was not
evenly distributed throughout glycosomes but was restricted to a few distinct foci within
each organelle.

Thirty-seven percent of the TbPex13.2 positive glycosomes (414

organelles analyzed) had one foci, 35% had two foci, and 24% had 3 or more. Of
Tbaldolase positive glycosomes, approximately 4% had no visible TbPex13.2 foci (Fig.
4E).
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Figure 3.4. Epitope tagged Myc-TbPex13.2 localizes to glycosomes. (A,B) Cells were
fixed, permeabilized, and stained with antibodies against myc (green) and Tbaldolase or
TbBiP (magenta).

Representative images of maximum intensity projections of

deconvolved Z-stacks are shown. Scale bar indicates 5 μm. (C) Plots of Mander’s
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overlap coefficients and Manders M1 and M2 values were calculated from individual cells
using Z-stacks with the Mander’s coefficient plugin in FIJI. Each point represents analysis
of one cell. Myc-TbPex13.2 and TbAldolase n=34. mycTbPex13.2 and TbBiP n=27. (D)
MOC, M1 and M2 values. (E) Pie chart representing the number of mycTbPex13.2 foci
per organelle.

Silencing of TbPex13.2 in PF parasites reduced import efficiency of PTS2 proteins
Prior work revealed that silencing TbPex13.2 in BSF parasites was detrimental (14). At
that time PF RNAi cell lines could not be established. We were able to silence TbPex13.2
in both PF and BSF parasites via inducible RNA interference and western analysis
indicated that TbPex13.2 levels were reduced ~95% upon induction of RNAi (Fig. 3.5A).
Silencing of TbPex13.2 did not alter the overall expression levels of the glycosome matrix
protein Tbaldolase, or the glycosome membrane proteins TbPex13.1 or TbPex14 (Fig.
3.5A) in BSF or PF parasites. Using densitometry, the protein knockdown upon RNAi
induction was quantified from 5 replicate western blots.

In PF cells 96.1 ± 1.4%

knockdown was observed; however, 33.1 ± 14.2% knockdown was observed in BSF cells.
While we observed no change in growth rate after induction of RNAi in PF parasites (Fig.
3.5C), BSF growth was slowed upon induction of silencing (Fig. 3.5D) as reported
previously (14).
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Figure 3.5. Silencing of Pex13.2 does not influence expression of other glycosome
proteins and does not have a detrimental effect on growth rate. (A) Cultures were
grown for 96 h and 5x106 cells were analyzed by western blotting with antibodies against
TbPex13.2, TbPex13.1, aldolase, and TbPex14.

Tubulin was used as a loading

control. (B) Densitometry quantification of TbPex13.2 from five replicates of western blots
shown in panel A. Growth curves for PF (C) and BSF (D) parasites grown with and without
doxycycline.

In higher eukaryotes, Pex13 functions in peroxisomal protein import.

We used

immunofluorescence assays (IFA) to determine if TbPex13.2 silencing altered glycosome
protein import in PF parasites. In uninduced cells, the glycosome proteins Tbaldolase,
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TbHK, TbFBP and TbPFK all localized to punctate structures characteristic of glycosomes
(Fig. 6A). After 4 days of induction, IFA revealed an increase in the cytosolic localization
of Tbaldolase. In contrast, the localization of TbHK, TbFBP, and TbPFK was not altered
in these cells. Under standard culturing conditions in SDM79 media (5 mM glucose), the
mislocalization of glycosome proteins is generally lethal. Previous work has shown that
removal of glucose from the media rescues this phenotype (30). We measured glycosome
protein localization in low-glucose media (SDM79θ, 5 μM glucose) with the expectation
that under these conditions we could score phenotypes that would be lethal in cells grown
in SDM79. When cells were grown in SDM79θ, tet-induced mislocalization of Tbaldolase
was increased. In contrast, even in low-glucose conditions, the TbHK, TbFBP and TbPFK
localization was not altered upon TbPex13.2 silencing.
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Figure 3.6. Silencing of Pex13.2 results in mislocalization of a subset of glycosome
proteins. (A) IFA of PF cells grown in the presence or absence of doxycycline. Cells
were labeled with antibodies against Tbaldolase, Tbhexokinase, and fructose 1,6bisphosphatase (TbFBP) and detected using goat anti-rabbit secondary antibodies
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conjugated with Alexa Flour 488 (Green). Nuclear and kinetoplast DNA were stained with
DAPI (Blue). Scale bars represent 5 μm. (B) Live cell microscopy of cells constitutively
expressing eYFP fused with the peroxisome targeting sequence 2 (PTS2) of aldolase or
hexokinase (Green).

Scale bars represent 5 μm.

(C) Biochemical analysis of

mislocalization. Cells were lysed by silicon carbide abrasive and were centrifuged to
obtain an organelle enriched pellet. Cytosol proteins in supernatant were precipitated
using 4 volumes of acetone. Samples were separated by SDS-PAGE and analyzed by
western blot. Mislocalization was quantified by densitometry of three biological replicates
using ImageJ.

To quantify import efficiencies of each protein, we used western analysis to determine the
percent of protein associated with organelle fractions in uninduced and induced
TbPex13.2 RNAi cell lines. Cells were lysed and centrifuged to obtain a membrane-rich
fraction and western analysis used to calculate the percentage of each protein associated
with membrane (glycosomes) and soluble (cytosolic) fractions (Fig. 3.6C). In uninduced
cells cultured in SDM-79, 58 ± 5% of Tbaldolase was associated with the pellet compared
to 48.5 ± 5% in induced cells. This mislocalization was increased in low glucose media
with 58.5 ± 5% associated with the pellet in uninduced cells and 38 ± 4% in TbPex13.2
silenced cells. In contrast, Tbaldolase, TbFBP, TbPFK, and TbHK localization did not
change significantly when TbPex13.2 was silenced in high or low glucose media. While
both TbHK and Tbaldolase have type 2 peroxisomal targeting sequences (PTS2s), only
Tbaldolase localization was affected by TbPex13.2 silencing. To assess the extent to
which each PTS2 sequence contributed to this TbPex13.2-dependent localization, we
followed the localization of eYFP fused to either the PTS2 of Tbaldolase or TbHK.
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Fluorescence microscopy of living cells revealed that both TbAldoPTS2eYFP and
TbHKPTS2eYFP were mislocalized to the cytoplasm in TbPex13.2 deficient cells (Fig.
6B).

We next used transmission electron microscopy (TEM) to determine how depletion of
TbPex13.2 altered overall glycosome morphology (Fig. 3.7A). Under these conditions,
glycosomes are spherical, electron dense organelles.

This analysis of TbPex13.2-

deficient cells did not reveal a significant difference in glycosome morphology as
compared to wild-type cells. Silencing of TbPex13.2 did not affect glycosome area (Figure
3.7B). In SDM79 media, glycosomes comprised 3.67% ± 1.76% and 2.14% ± 0.84% of
the cell volume in wild-type or TbPex13.2-deficient cells, respectively. In SDM79θ media,
glycosomes comprised 6.18% ± 1.75% and 5.77% ± 2.11% of the cell volume in wild-type
or TbPex13.2-deficient cells, respectively.

97

Figure 3.7. Electron microscopy of TbPex13.2 deficient cells. (A) EM analysis of
wildtype and cells induced for RNAi shows that there is not a dramatic morphological
change due to silencing of TbPex13.2. (B) Analysis of glycosome size and area as a
percentage of cell area. 25 images and at least 36 glycosomes per condition were
measured. ns: not significant.
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We reasoned that TbPex13.2 silencing may interfere with the import of proteins for which
we have no antibodies. Additionally, depletion of a protein localized to the glycosome
membrane may affect other biochemical properties such as density. To assess this, we
resolved organelles on a sucrose/Optiprep gradient and followed sedimentation via
western analysis of glycosomal proteins (Figure 3.8). In uninduced cells, Tbaldolase and
TbPex14 were detected in fractions 10-16 as is typical for glycosome proteins. In induced
cells, however, these proteins were detected in higher fractions (4-16) suggesting that
glycosomes in TbPex13.2 deficient cells are less dense than those isolated from parental
cells.

In contrast, western analysis with anti-TbBiP antibodies revealed that the

sedimentation of the ER was not altered in TbPex13.2 deficient cells. Densitometry
analysis was performed, and the percentage of protein signal was plotted (Figure 3.8B).
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Figure 3.8. Glycosomes from TbPex13.2 deficient cells are less dense. (A) Cells
(5x108) were harvested, lysed mechanically with silicon carbide and the glycosome
enriched pellet and resolved on a linear Optiprep gradient. Fractions were taken from the
top of the gradient and analyzed by western blotting. Boxes indicate glycosome fractions.
(B) Western blot bands were quantified using densitometry and the percentage of protein
was plotted. Presented are representative blots from three biological replicates.
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Discussion
Throughout the lifecycle of T. brucei, the parasites experience multiple environments. The
procyclic form (PF) parasites within the tsetse fly insect vector are able to metabolize
amino acids; however, within the mammalian host the bloodstream form (BSF) parasites
rely on glycolysis for ATP production. In kinetoplastids, the majority of the glycolytic
pathway is compartmentalized within glycosomes and disruption of compartmentalization
is lethal under standard conditions (5, 8, 30–32). As glycosomes are essential organelles
in kinetoplastids, the mechanisms for their maintenance are attractive drug targets (4, 33,
34). In this study, we have demonstrated that TbPex13.2 is a member of the glycosome
docking complex and facilitates the import of a subset of glycosomal matrix proteins.

Like peroxisomes, glycosomes do not have DNA and all matrix proteins are imported posttranslationally in a process that is fairly well-conserved. Glycosome and peroxisome matrix
proteins are synthesized in the cytoplasm where they are identified by the soluble
receptors, Pex5 and Pex7, which recognize peroxisomal targeting sequence (PTS) 1 and
PTS2, respectively (8). The receptor:cargo complex is then targeted to the receptor
docking complex on the glycosome/peroxisome membrane containing the proteins Pex13
and Pex14 (7, 12, 35). T. brucei is unusual in that it has two Pex13s, which have been
named TbPex13.1 and TbPex13.2. The two proteins share low overall sequence identity
with each other or with other Pex13s. TbPex13.1 was the first to be identified in T. brucei.
Fusions with green fluorescent protein localized to glycosomes and silencing TbPex13.1
resulted in glycosome protein mislocalization and cell death. TbPex13.2 was identified
later and silencing of this protein in bloodstream parasites also resulted in glycosome
protein mislocalization and cell death. These findings indicate that the two proteins are
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not redundant, however, the specific role that each plays in glycosome biogenesis is
unclear.

Here we report the characterization of TbPex13.2 and a phenotypic characterization of
RNA interference cell lines in which TbPex13.2 is silenced. In agreement with previous
work, we found that silencing TbPex13.2 slowed the growth rate of BSF parasites (14).
While the effect we observed was not as dramatic as previous work, this is likely due to
variation in penetrance. As previously observed with the tagged TbPex13.2, we found
that native TbPex13.2 was an integral glycosome membrane protein. Furthermore, we
were able to demonstrate through protease protection assays that the N-terminus of
TbPex13.2 is exposed to the cytosol where it can interact with proteins involved in protein
import. Unfortunately, we could not express C-terminally tagged TbPex13.2 in T. brucei
and were not able to determine if the C-terminus is localized to the cytosolic or matrix side
of the glycosome.

We found that Tbaldolase, which has a PTS2 sequence was mislocalized in TbPex13.2deficient parasites while the import of PFK harboring a PTS1 was not affected. During the
import process, Pex7 binds to the N-terminus of Pex13 that is comprised of a YG rich
sequence in Saccharomyces cerevisiae

and Arabidopsis thaliana (36, 37).

Both

TbPex13.1 and TbPex13.2 have a similar YG rich domain in their N-termini. It may be
that depletion of TbPex13.2 reduces the number of Pex7 binding sites at the glycosome
membrane resulting in reduced PTS2 import while having minimal effect on protein import
of PTS1 proteins such as PFK. TbFBP import was not affected, however, this protein has
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both a PTS1 and PTS2 sequence and may be imported by a combination of PTS1 and
PTS2 import pathways.

In previous studies using BSF parasites, digitonin extractions revealed that silencing
TbPex13.2 impaired import of both PTS1 and PTS2 proteins (14). As yet, we have not
observed defects in PF PTS1 import; however, there are several potential explanations
for this. Brennand et al. followed glycosomal GAPDH, which is targeted via a PTS1.
Because of antibody availability, we followed PFK, which is also targeted to glycosomes
by a PTS1. Alternatively, the differences may be a consequence of the methods used to
assess import. Previous studies utilized digitonin fractionations while we measured import
via IFA and quantification of organelle associated proteins.

The receptor Pex7, unlike Pex5, is necessary but not sufficient for PTS2 protein import
and several PTS2 co-receptors have been described. These co-receptors are speciesspecific and include Pex18 and Pex21p in Saccharomyces cerevisiae (38), Pex20p in
Yarrowia lipolytica (39), and the long isoform of Pex5 (Pex5L) in mammals (40). All three
co-receptors have Pex7-binding domains. T. brucei has two isoforms of Pex5, however,
the functional significance of the two forms are very different from what is observed in
mammals. Whereas, HsPex5L is a splicing variant with an internal Pex7BD, TbPex5L is
the full-length protein while the shorter form is a result of a proteolytic cleavage (41).
Therefore, a co-receptor has not yet been identified in T. brucei. It is attractive to speculate
that TbPex13.2 may be playing this role in kinetoplastids.
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We were surprised to find that Tbaldolase and TbHK, which both have PTS2s, behaved
differently in TbPex13.2 deficient cells. Tbaldolase import was disrupted while TbHK was
not. We imagine two possible scenarios for these results. It is possible that not all PTS2s
are created equal. Alternatively, there may be information outside of the PTS2 sequence
that influences the glycosome localization of TbHK. To discern which scenario was at
play, we fused the PTS2 of TbHK and the PTS2 of Tbaldolase to enhanced yellow
fluorescent protein (eYFP) and found that the import of each is disrupted in TbPex13.2deficient cells. This finding indicates TbPex13.2 is required for efficient import of both
PTSs and reveals that that TbHK contains information for glycosomal localization outside
of the PTS2 sequence.

The formation of myc-TbPex13.2 foci on the glycosome membrane was interesting
because of its similarity to the localization of other import process-related peroxins in other
systems. Recent super-resolution studies of peroxisomes have provided insight into the
heterogeneous distribution of different peroxins within peroxisomes (29). Membranebound Pex5 and Pex14 generally colocalized in structures that range in shape from round
to elliptical, ring-like structures. Pex11, which functions in peroxisome proliferation and
not protein import, and a soluble matrix protein SCP2 also exhibit heterogenous
distribution. The functional relevance of these distribution patterns is unclear; however,
the use of super-resolution imaging is essential to resolving the mechanism and
consequence of such localization patterns. To our knowledge, this is the only example of
heterogenous intra-glycosomal localization of peroxins in parasites and future studies are
necessary to understand the significance of such localizations.
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Figure S3.1. Higher molecular weight bands are not multimers of TbPex13.2.
Bloodstream form (106) lysates were treated with DTT to reduce disulfide bonds and
NEM to block free reactive thiols to prevent dimerization post lysis. Lysates were
resolved by SDS-PAGE and western blots probed with α-TbPex13.2 antibodies. Asterisk
indicates non-specific cross-reactive band.

106

References
1.

T. Gabaldón, M. L. Ginger, P. A. M. Michels, Peroxisomes in parasitic protists. Mol.
Biochem. Parasitol. (2016), doi:10.1016/j.molbiopara.2016.02.005.

2.

M. Parsons, T. Furuya, S. Pal, P. Kessler, Biogenesis and function of peroxisomes
and glycosomes. Mol. Biochem. Parasitol. 115, 19–28 (2001).

3.

J. Moyersoen, J. Choe, E. Fan, W. G. J. Hol, P. a M. Michels, Biogenesis of
peroxisomes and glycosomes: Trypanosomatid glycosome assembly is a promising
new drug target. FEMS Microbiol. Rev. 28, 603–643 (2004).

4.

J. R. Haanstra, A. van Tuijl, P. Kessler, W. Reijnders, P. A. M. Michels, H. V
Westerhoff, M. Parsons, B. M. Bakker, Compartmentation prevents a lethal turboexplosion of glycolysis in trypanosomes. Proc. Natl. Acad. Sci. U. S. A. 105, 17718–
23 (2008).

5.

C. Guerra-Giraldez, L. Quijada, C. E. Clayton, Compartmentation of enzymes in a
microbody, the glycosome, is essential in Trypanosoma brucei. J. Cell Sci. 115,
2651–2658 (2002).

6.

V. C. Kalel, L. Emmanouilidis, M. Dawidowski, W. Schliebs, M. Sattler, G. M.
Popowicz, R. Erdmann, Inhibitors of glycosomal protein import provide new leads
against trypanosomiasis. Microb. cell (Graz, Austria). 4, 229–232 (2017).

7.

J. J. Smith, J. D. Aitchison, Peroxisomes take shape. Nat. Rev. Mol. Cell Biol. 14,
803–17 (2013).

107

8.

N. Galland, F. Demeure, V. Hannaert, E. Verplaetse, D. Vertommen, P. Van Der
Smissen, P. J. Courtoy, P. A. M. Michels, Characterization of the role of the
receptors PEX5 and PEX7 in the import of proteins into glycosomes of
Trypanosoma brucei. Biochim. Biophys. Acta - Mol. Cell Res. 1773, 521–535
(2007).

9.

P. K. Kim, E. H. Hettema, Multiple pathways for protein transport to peroxisomes.
J. Mol. Biol. 427, 1176–1190 (2015).

10.

S. J. Gould, G. A. Keller, N. Hosken, J. Wilkinson, S. Subramani, A conserved
tripeptide sorts proteins to peroxisomes. J. Cell Biol. 108, 1657–1664 (1989).

11.

P. Rehling, M. Marzioch, F. Niesen, E. Wittke, M. Veenhuis, W. H. Kunau, The
import receptor for the peroxisomal targeting signal 2 (PTS2) in Saccharomyces
cerevisiae is encoded by the PAS7 gene. EMBO J. 15, 2901–13 (1996).

12.

C. Williams, B. Distel, Pex13p: Docking or cargo handling protein? Biochim.
Biophys. Acta - Mol. Cell Res. 1763, 1585–1591 (2006).

13.

T. Saveria, P. Kessler, B. C. Jensen, M. Parsons, Characterization of glycosomal
RING finger proteins of trypanosomatids. Exp. Parasitol. 116, 14–24 (2007).

14.

A. Brennand, D. J. Rigden, P. A. M. Michels, Trypanosomes contain two highly
different isoforms of peroxin PEX13 involved in glycosome biogenesis. FEBS Lett.
586, 1765–1771 (2012).

15.

E. Verplaetse, D. J. Rigden, P. A. M. Michels, Identification, characterization and
essentiality of the unusual peroxin 13 from Trypanosoma brucei. Biochim. Biophys.
Acta - Mol. Cell Res. 1793, 516–527 (2009).

16.

E. Wirtz, C. Clayton, Inducible gene expression in trypanosomes mediated by a
prokaryotic repressor. Science. 268, 1179–83 (1995).

108

17.

Y. Qiu, J. E. Milanes, J. A. Jones, R. E. Noorai, V. Shankar, J. C. Morris, Glucose
Signaling Is Important for Nutrient Adaptation during Differentiation of Pleomorphic
African Trypanosomes (2018), doi:10.1128/mSphere.00366-18.

18.

H. Hirumi, K. Hirumi, Continuous cultivation of Trypanosoma brucei blood stream
forms in a medium containing a low concentration of serum protein without feeder
cell layers. J. Parasitol. 75, 985–9 (1989).

19.

J. D. Bangs, E. M. Brouch, D. M. Ransom, J. L. Roggy, A soluble secretory reporter
system in Trypanosoma brucei. Studies on endoplasmic reticulum targeting. J. Biol.
Chem. 271, 18387–18393 (1996).

20.

Z. Wang, J. C. Morris, M. E. Drew, P. T. Englund, Inhibition of Trypanosoma brucei
gene expression by RNA interference using an integratable vector with opposing
T7 promoters. J. Biol. Chem. 275, 40174–40179 (2000).

21.

QIAGEN, The QIA expressionist TM-His tag proteins (2003).

22.

C. Colasante, M. Ellis, T. Ruppert, F. Voncken, Comparative proteomics of
glycosomes from bloodstream form and procyclic culture form Trypanosoma brucei
brucei. Proteomics. 6, 3275–3293 (2006).

23.

P. Lorenz, A. G. Maier, E. Baumgart, R. Erdmann, C. Clayton, Elongation and
clustering of glycosomes in Trypanosoma brucei overexpressing the glycosomal
Pex11p. EMBO J. 17, 3542–3555 (1998).

24.

S. Bauer, J. C. Morris, M. T. Morris, Environmentally regulated glycosome protein
composition in the African trypanosome. Eukaryot. Cell. 12, 1072–1079 (2013).

109

25.

J. Schindelin, I. Arganda-Carreras, E. Frise, V. Kaynig, M. Longair, T. Pietzsch, S.
Preibisch, C. Rueden, S. Saalfeld, B. Schmid, J.-Y. Tinevez, D. J. White, V.
Hartenstein, K. Eliceiri, P. Tomancak, A. Cardona, Fiji: an open-source platform for
biological-image analysis. Nat. Methods. 9, 676–82 (2012).

26.

A. Krogh, B. Larsson, G. Von Heijne, E. L. L. Sonnhammer, Predicting
transmembrane protein topology with a hidden Markov model: Application to
complete genomes. J. Mol. Biol. 305, 567–580 (2001).

27.

C. E. Clayton, Import of fructose bisphosphate aldolase into the glycosomes of
Trypanosoma brucei. J. Cell Biol. 105, 2649–2654 (1987).

28.

V. Zinchuk, O. Zinchuk, T. Okada, Quantitative Colocalization Analysis of Multicolor
Confocal Immunofluorescence Microscopy Images: Pushing Pixels to Explore
Biological Phenomena. Acta Histochem. Cytochem. 40, 101–111 (2007).

29.

S. Galiani, D. Waithe, K. Reglinski, L. D. Cruz-Zaragoza, E. Garcia, M. P. Clausen,
W. Schliebs, R. Erdmann, C. Eggeling, Super-resolution microscopy reveals
compartmentalization of peroxisomal membrane proteins. J. Biol. Chem. 291,
16948–16962 (2016).

30.

T. Furuya, P. Kessler, A. Jardim, A. Schnaufer, C. Crudder, M. Parsons, Glucose
is toxic to glycosome-deficient trypanosomes. Proc. Natl. Acad. Sci. U. S. A. 99,
14177–14182 (2002).

31.

S. K. Banerjee, P. S. Kessler, T. Saveria, M. Parsons, Identification of
trypanosomatid PEX19: Functional characterization reveals impact on cell growth
and glycosome size and number. Mol. Biochem. Parasitol. 142, 47–55 (2005).

110

32.

V. C. Kalel, W. Schliebs, R. Erdmann, Identification and functional characterization
of Trypanosoma brucei peroxin 16. Biochim. Biophys. Acta - Mol. Cell Res. (2015),
doi:10.1016/j.bbamcr.2015.05.024.

33.

P. a M. Michels, F. Bringaud, M. Herman, V. Hannaert, Metabolic functions of
glycosomes in trypanosomatids. Biochim. Biophys. Acta - Mol. Cell Res. 1763,
1463–1477 (2006).

34.

M. Parsons, Glycosomes: Parasites and the divergence of peroxisomal purpose.
Mol. Microbiol. 53, 717–724 (2004).

35.

A. Schell-Steven, K. Stein, M. Amoros, C. Landgraf, R. Volkmer-Engert, H.
Rottensteiner, R. Erdmann, Identification of a novel, intraperoxisomal pex14binding site in pex13: association of pex13 with the docking complex is essential
for peroxisomal matrix protein import. Mol. Cell. Biol. 25, 3007–3018 (2005).

36.

K. Stein, A. Schell-Steven, R. Erdmann, H. Rottensteiner, Interactions of Pex7p and
Pex18p/Pex21p with the peroxisomal docking machinery: implications for the first
steps in PTS2 protein import. Mol. Cell. Biol. 22, 6056–69 (2002).

37.

S. Mano, C. Nakamori, K. Nito, M. Kondo, M. Nishimura, The Arabidopsis pex12
and pex13 mutants are defective in both PTS1- and PTS2-dependent protein
transport to peroxisomes. Plant J. 47, 604–618 (2006).

38.

P. E. Purdue, X. Yang, P. B. Lazarow, Pex18p and Pex21p, a novel pair of related
peroxins essential for peroxisomal targeting by the PTS2 pathway. J. Cell Biol. 143,
1859–1869 (1998).

39.

V. I. Titorenko, J. J. Smith, R. K. Szilard, R. A. Rachubinski, Pex20p of the yeast
Yarrowia lipolytica is required for the oligomerization of thiolase in the cytosol and
for its targeting to the peroxisome. J. Cell Biol. 142, 403–20 (1998).

111

40.

M. Kunze, N. Malkani, S. Maurer-Stroh, C. Wiesinger, J. A. Schmid, J. Berger,
Mechanistic insights into PTS2-mediated peroxisomal protein import: the coreceptor PEX5L drastically increases the interaction strength between the cargo
protein and the receptor PEX7. J. Biol. Chem. 290, 4928–40 (2015).

41.

M. Gualdrón-López, P. A. M. Michels, Processing of the glycosomal matrix-protein
import receptor PEX5 of Trypanosoma brucei. Biochem. Biophys. Res. Commun.
431, 98–103 (2013).

112

CHAPTER FOUR

Organization of the unique glycosomal translocation complex in Trypanosoma brucei

Logan P. Crowe1, Christina L. Wilkinson1, Emily W. Knight1, and Meredith Morris1,2

1

Eukaryotic Innovation Center, Department of Genetics and Biochemistry

Clemson University
Clemson, SC 29631

2

Corresponding author

113

Abstract

Peroxisomes are small, single membrane bound organelles that are ubiquitous among
eukaryotes. The protein content of these organelles is varied and dependent on organism
and environmental cues. Because peroxisomes do not possess DNA of their own, all
matrix proteins are translated on free ribosomes and imported from the cytosol via the
action of proteins called peroxins (Pex). Matrix proteins typically possess a peroxisomal
targeting sequence (PTS) type 1 or type 2, which is recognized by the cytosolic receptors
Pex5 and Pex7, respectively. The cytosolic receptors then direct the cargo to the docking
and translocation machinery (DTM) comprised primarily of Pex13 and Pex14. Following
docking of the receptor:cargo complex, the proteins are translocated into the organelle by
a poorly understood mechanism. Once the proteins are imported, Pex5 and Pex7 are
recycled to the cytosol. Kinetoplastids, including Trypanosoma brucei, Trypanosoma
cruzi, and Leishmania spp. possess two distinct Pex13s, named Pex13.1 and Pex13.2.
These peroxins share little similarity between each other and with Pex13s of other
organisms but do share several conserved domains: an N-terminal YG-rich region, 2
transmembrane domains, and a C-terminal SH3 domain. In other systems, the N-terminal
YG-rich region interacts with Pex7 and the SH3 domain interacts with Pex14 and Pex5.
TbPex13.1 contains all three domains. TbPex13.2 harbors a YG-rich domain and two
predicted transmembrane domains but lacks the SH3 domain, which may have
implications for its interaction with Pex14 in forming the DTM.

In super-resolution

microscopy images, TbPex13.1 and TbPex13.2 signal do not completely overlap,
suggesting that a portion of these proteins exhibit distinct localization patterns.
Glycosomes are 0.1-0.2 μm in diameter and make up a large proportion of the cytoplasm
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and as such, determining the localization of proteins to individual organelles is challenging.
To address the possibility that TbPex13.1 and TbPex13.2 localize to distinct glycosome
populations, we adapted flow cytometry for single-organelle analysis. Results of those
experiments suggest that most vesicles are positive for both TbPex13.1 and TbPex13.2.
suggest 2-D Blue native SDS-PAGE showed that TbPex13.1, TbPex13.2 and TbPex14
form several higher molecular weight complexes and TbPex13.1 and TbPex13.2 interact
with each other and with TbPex14 in the DTM in targeted co-immunoprecipitation
experiments.

Identification of many PTS2 harboring proteins that were co-

immunoprecipitated with both TbPex13.1 and TbPex13.2 suggest a role for both peroxins
in the PTS2 import pathway; however, a majority of PTS1 harboring proteins were only
associated with TbPex13.1 co-IP, suggesting that the PTS1 import pathway is primarily
facilitated via TbPex13.1.
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Introduction
Peroxisomes are present in most eukaryotes and contain many processes that can be
tailored to specific cell needs and environmental conditions (1–3). Kinetoplastid parasites
such as Trypanosoma brucei, the protozoan parasite responsible for Human African
Trypanosomiasis (HAT), possess specialized peroxisomes that compartmentalize much
of the glycolytic pathway. These organelles have been named glycosomes to reflect this
unique composition (1, 4, 5). Due to the essential nature of these organelles in T. brucei,
glycosomes provide an attractive target for the treatment of African Trypanosomiasis (6,
7).

Peroxisomes and glycosomes lack DNA and import fully folded matrix proteins from the
cytosol post-translationally (8, 9). Peroxisomal matrix proteins typically possess either a
peroxisomal targeting signal (PTS) 1 or PTS2, which are recognized by the cytosolic
receptors Pex5 and Pex7, respectively (8, 10). Once the cargo is recognized by the
cytosolic receptors, it is directed to the docking complex on the peroxisomal membrane
comprised primarily of Pex13 and Pex14 and the cargo is imported into the organelle via
a mechanism that is not well understood (11–13).

The primary components of the

translocation machinery are Pex13, Pex14 and Pex5 in the PTS1 import pathway, with
various additional accessory proteins involved in the PTS2 import pathway (8, 10, 14).

Although the components of the docking and translocation module (DTM) have been
identified, there are contradictory reports on the organization of the complex (11, 15, 16).
In yeast, protease protection assays revealed the C terminus of Pex13 containing the SH3
domain is cytosolic, and the C-terminus of Pex14 is cytosolic with the N-terminus facing

116

the peroxisome matrix (15, 17–19). The SH3 domain of the yeast Pex13 binds with Pex5
and Pex14, and the N-terminal YG rich domain binds Pex7 and is involved in Pex13-Pex13
homooligomerization (14, 20, 21).

In addition to these proteins, several accessory

peroxins facilitate PTS2 mediated protein import, and interact with the N-terminal domain
of Pex13, suggesting that Pex13 plays a role in both pathways (14). In addition to Pex13Pex14 interaction mediated by the SH3 domain, there is a second intraperoxisomal
binding site, suggesting close interaction between the two proteins (15).

Kinetoplastids have two Pex13s: Pex13.1 and Pex13.2. Although their sequence similarity
with each other and other Pex13s is low, they have been localized to glycosomes and
implicated in glycosomal matrix protein import (22). In T. brucei, silencing of either peroxin
results in mislocalization of matrix proteins, and silencing of TbPex13.1 is lethal (17, 22).
TbPex13.1 maintains the traditional domain structure of other Pex13s, but interestingly
possesses a PTS1, an uncommon domain for peroxisomal membrane proteins that is not
present in other Pex13s (17). TbPex13.2, on the other hand, lacks the C-terminal SH3
domain (22). Because the SH3 domain mediates interactions with Pex5 and Pex14,
Pex13.2 may interact weakly or not at all with those proteins. Reduction of TbPex13.2
levels resulted in the mislocalization of PTS2 proteins indicating it is necessary for efficient
PTS2 protein import (23). While the DTM is comprised of Pex13 and Pex14 in other
model organisms, it is unclear how the presence of a second Pex13 influences complex
formation and import of matrix proteins (15, 21, 24).

In this work, we have used a number of approaches to resolve the localization and
composition of import complexes containing TbPex13.1 and TbPex13.2. Using super-
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resolution immunofluorescence microscopy, we

found that

HATbPex13.1

and

MycTbPex13.2 exhibit similar localization patterns with partial overlap. To study individual
glycosomes, we have developed a flow cytometry-based technique for high-throughput
analysis of purified organelles. A majority of the organelles were labeled with antibodies
that recognize HATbPex13.1 and MycTbPex13.2, suggesting that most glycosomes have
both Pex13s.

To determine the composition of the DTM, we utilized 2-dimensional blue native (BN) /
SDS-PAGE and co-immunoprecipitation coupled with mass spectrometry to determine
what complexes are formed by TbPex13s and TbPex14. We found that TbPex13.1 and
TbPex13.2 interact with each other and with Pex14 and form multiple complexes. We
propose a model with three possible DTM configurations: one has TbPex14 with 2
TbPex13.1s molecules, another containing only two 2 TbPex13.2 molecules, or
TbPex13.1 and TbPex13.2.
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Materials and methods

Cell culture and transfection of T. brucei:

Procyclic form (PCF) 29-13 parasites

expressing T7 polymerase under the regulation of the tetracycline (tet) repressor were
maintained in SDM-79 culture medium (25). Transgenic cell lines expressing epitope
tagged TbPex13.1 or TbPex13.2 were generated by cloning the open reading frame of
the respective genes fused to HA and Myc to generate HATbPex13.1 and MycTbPex13.2
into the pXS2 vector for constitutive expression with either blasticidin or puromycin
resistance markers (26). Enhanced YFP (eYFP) tagged-TbPex13.1 was expressed by
cloning eYFP open reading frame fused to the N terminus of TbPex13.1 into the pLEW
expression vector under the regulation of the tet repressor. Plasmids (20 μg) were
digested with MluI (pXS2) or NotI (pLEW) to linearize, cells were electroporated in 4 mm
cuvettes (BioRad GenePulser Xcell; exponential, 1.5 kV, 25 μF), and selector drug was
added 24 h post-electroporation (15 μg/ml G418; 50 μg/ml hygromycin; 1 μg/ml
puromycin; 2.5 μg/ml phleomycin; 10 μg/ml blasticidin). Doxycycline (1 μg/ml) was added
to induce expression of eYFP-TbPex13.1.

Immunofluorescence microscopy: Cells were pelleted (800g, 10 min), washed 1x with
PBS, fixed with 2% paraformaldehyde in PBS at RT for 30 min and allowed to settle on
slides for 30 min. Cells adhered to slides were washed 1x with wash solution (0.1% normal
goat serum in 1x PBS), permeabilized 15 min (0.5% Triton X-100 in 1x PBS), blocked 1 h
(10% normal goat serum, 0.1% Triton X-100 in 1x PBS), and stained with primary
antibodies for Myc (C-Myc, Thermo Fisher 9E10 1:500) and HA (HA-Tag, Cell Signaling
Technology C29F4 1:500) for 1 h in block solution. Cells were washed 3x with wash
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solution and incubated 1 h with secondary antibody in block solution (Thermo Fisher, goat
anti-mouse Alexa fluor 488 1:1,000; goat anti-rabbit Alexa fluor 647 1:1,000). Cells were
finally washed 3x with wash solution and antifade was added (Vectashield, Vector
Laboratories). Images were taken using a Leica SP8X microscope with 63x (N.A. 1.4)
objective and HyD detector configuration. Image analysis performed using ImageJ.

Sucrose gradient fractionation: Fractionation of WT cells was carried out as described
(23). Fractions (500 μl) were collected from the top of the gradient and 2.5 μg protein
resolved on a 12% SDS-PAGE gel. Analysis was performed by western blotting using
antibodies against BiP (1:100,000), aldolase (1:20,000), TbPex13.1 (1:5,000) and
TbPex13.2 (1:10,000).

Immunoaffinity purification of glycosomes: Intact organelles were purified using PCF
parasites expressing N-terminally epitope tagged HATbPex13.1 and MycTbPex13.2 via
magnetic beads coated with anti-HA or anti-Myc antibodies. Cells (2 x109) were harvested
at 800g for 10 min, washed 2x with PBS, and mechanically lysed using silicon carbide
slurry in STE buffer (250 mM sucrose, 25 mM Tris-HCl pH7.4, 1mM EDTA) supplemented
with EDTA-free Pierce protease inhibitor tablet (Thermo Fisher). Lysates were centrifuged
(5k xg, 10 min, 4oC) to remove cell debris, nuclei, and other large organelles. The resulting
glycosome enriched fraction was incubated with 100 μl magnetic beads with either HA or
Myc antibodies (Thermo Fisher) and incubated rotating at 4oC overnight. Magnetic beads
were removed using a magnet, washed 3x with STE, and resuspended in 100 μl PBS.
Protein (5 μl bead slurry) was analyzed by SDS-PAGE and western blotting.
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Electron microscopy: Analysis of glycosomes captured on the magnetic beads was
performed using scanning electron microscopy (SEM). Beads with captured organelles
were fixed with 4% paraformaldehyde and 0.25% glutaraldehyde overnight at 4oC, washed
with PBS, and washed 2x with sodium cacodylate buffer (0.1 M, pH 7.2, 30 min, room
temp). Samples were incubated in 1% aqueous osmium tetraoxide 1 h at room temp, and
washed 2x 15 min with dH2O. After washing, samples were dehydrated with graded
ethanol series: 50% EtOH 5 min, 70% EtOH 5 min, 80% EtOH 10 min, 95% EtOH 10 min,
and finally 100% EtOH 2x 10 min. Samples were further dried using hexamethyldisilazane
(HMDS) as follows: 3:1 EtOH:HMDS 1x 15 min, 1:1 EtOH:HMDS 1x 15 min, 1:3
EtOH:HMDS 1x 15 min, and finally 100% HMDS. Samples were spotted onto silicon
wafers and allowed to dry overnight. The following day specimens on stubs were coated
with palladium using sputter coater and imaged on a Hitachi S-4800 SEM.

Co-immunoprecipitations: Cells (2 x109) constitutively expressing HATbPex13.1 and
MycTbPex13.2 were harvested at 800g for 10 minutes, and washed 2x with PBS. Cells
were incubated with 2.5 M DTSSP (3,3’-dithiobis[sulfosuccinimidylpropinoate]) 30 min,
Tris pH 7.5 was added to a final concentration of 50 mM, and lysed by resuspending in
hypotonic lysis buffer 1 (HB1) (100 μM TLCK (tosyl phenylalanyl chloromethyl ketone), 1
μg/ml leupeptin) and incubating on ice 20 min. An equal volume of hypotonic lysis buffer
2 (HB2) was added (100 mM Hepes-KOH pH 8, 50 mM KCl, 10 mM MgCl2, 20% (v/v)
glycerol, 100 μM TLCK, 1 μg/ml leupeptin). Lysates were passed through a 28g needle
5x, centrifuged (17k xg, 10 min, 4oC), and clarified lysate (L1) was transferred to a fresh
tube. The pellet was resuspended in equal volumes HB1 and HB2, supplemented with
0.5% IGEPAL, incubated on ice 20 min and centrifuged (17k xg, 10 min, 4oC) and clarified
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lysate (L2) was transferred to a fresh tube. Each lysate (L1 and L2) was aliquoted into
two tubes and 100 μl magnetic anti-HA or anti-Myc beads were added. Samples were
incubated rotating overnight at 4oC, beads separated using a magnetic rack, washed 3x
with 5x TBS-T (100 mM Tris pH 7.5, 750 mM NaCl, 0.5% Tween 20), washed 1x in
nanopure water, and resuspended in 100 μl nanopure water.

Samples were then

analyzed by SDS-PAGE, western blotting and mass spectrometry.

LC-MS/MS analysis of Co-IP: Co-IP samples on magnetic beads were boiled at 100oC
and resolved on a NuPAGE Bis-Tris 4-12% gradient gel (ThermoFisher). Each SDSPAGE gel lane was sectioned into 12 segments of equal volume and subjected to in-gel
trypsin digestion as follows. Gel slices were destained in 50% methanol (Fisher), 100 mM
ammonium bicarbonate (Sigma-Aldrich), followed by reduction in 10 mM Tris[2carboxyethyl]phosphine (Pierce) and alkylation in 50 mM iodoacetamide (Sigma-Aldrich).
Gel slices were then dehydrated in acetonitrile (Fisher), followed by addition of 100 ng
porcine sequencing grade modified trypsin (Promega) in 100 mM ammonium bicarbonate
(Sigma-Aldrich) and incubation at 37oC for 12-16 hours. Peptide products were then
acidified in 0.1% formic acid (Pierce). Tryptic peptides were separated by reverse phase
XSelect CSH C18 2.5 um resin (Waters) on an in-line 150 x 0.075 mm column using a
nanoAcquity UPLC system (Waters). Peptides were eluted using a 30 min gradient from
97:3 to 67:33 buffer A:B ratio. [Buffer A = 0.1% formic acid, 0.5% acetonitrile; buffer B =
0.1% formic acid, 99.9% acetonitrile.] Eluted peptides were ionized by electrospray (2.15
kV) followed by MS/MS analysis using higher-energy collisional dissociation (HCD) on an
Orbitrap Fusion Tribrid mass spectrometer (Thermo) in top-speed data-dependent mode.
MS data were acquired using the FTMS analyzer in profile mode at a resolution of 240,000
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over a range of 375 to 1500 m/z. Following HCD activation, MS/MS data were acquired
using the ion trap analyzer in centroid mode and normal mass range with precursor massdependent normalized collision energy between 28.0 and 31.0.

Proteins and post-

translational modifications were identified by database search using Mascot (Matrix
Science) with a parent ion tolerance of 3 ppm and a fragment ion tolerance of 0.5 Da.
Scaffold (Proteome Software) was used to verify MS/MS based peptide and protein
identifications. Peptide identifications were accepted if they could be established with less
than 1.0% false discovery by the Scaffold Local FDR algorithm. Protein identifications
were accepted if they could be established with less than 1.0% false discovery and
contained at least 2 identified peptides. Protein probabilities were assigned by the Protein
Prophet algorithm (27).

2-Dimensional Blue Native (BN)/SDS-PAGE: An organelle-enriched pellet from 108
cells was prepared as previously described and resuspended in 1x sample buffer (1% ndodecyl-β-D- maltoside, 0.75 M 6-aminocaprotic acid, 0.5% Coomassie brilliant blueG250, 50 mM Bis-Tris pH 7.0, 0.5 mM EDTA). Samples were then incubated rotating at
4oC for 1 h and centrifuged (100k xg, 15 min, 4oC) to remove insoluble material. The
supernatant was resolved by blue-native PAGE (Invitrogen Novex NativePage 4-16% BisTris gel; Blue cathode buffer: 50 mM Tricine-NaOH pH 7.0, 15 mM Bis-Tris-HCl, 0.02%
Coomassie brilliant blue G-250; Anode buffer: 50 mM Bis-Tris-HCl pH 7.0). When dye
front migrated ~1/3 through the gel, cathode buffer was exchanged for a clear cathode
buffer (without CBB). To analyze in second dimension SDS-PAGE, individual lanes were
excised, incubated in warm SDS-PAGE running buffer, and overlayed on a 12% SDSPAGE gel. After transfer to nitrocellulose membranes, proteins were analyzed by western
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blotting using antibodies against TbPex13.1 (1:5,000), TbPex13.2 (1:10,000), and
TbPex14 (Provided by Dr. Armando Jardim, McGill University, Quebec, Canada;
1:20,000).

Flow cytometry analysis of organelles: Organelles were prepared by mechanically
lysing cells as described previously. Post nuclear lysate was fixed by addition of 16%
paraformaldehyde drop-wise while gently vortexing and incubated for 15 min on a rotator
at 4oC. Fixed organelles were pelleted at 17,000 xg, resuspended in permeabilization
solution (0.5% Triton X-100 in 1x PBS) for 15 min at RT, washed 2x with 1x PBS, and
incubated in block solution (10% normal goat serum, 0.1% Triton X-100 in 1x PBS) 1 h at
RT. Primary antibodies Myc (C-Myc, Thermo Fisher 9E10 1:500) and HA (HA-Tag, Cell
Signaling Technology C29F4 1:500) were added and incubated 1 h at RT. Organelles
were washed 2x with 1x PBS, resuspended in block solution with secondary antibodies:
anti-mouse conjugated with Pacific Orange (Thermo Fisher Scientific P31858 1:500) and
anti-rabbit conjugated with Alexa 405 (Thermo Fisher Scientific A-31556 1:500) and
incubated 30 min at RT. Organelles were washed 2x with 1x PBS and resuspended in 1
ml 1x PBS. Analysis was performed using a Beckman-Coulter CytoFLEX flow cytometer.
Samples were thresholded by SSC-H and gated by FSC-H and SSC-width.
Compensation was performed using single-stained samples.
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Results

TbPex13.1 and TbPex13.2 domain structure suggests they are involved in different
protein interactions
Although TbPex13.1 and TbPex13.2 have little sequence similarity, they possess domains
characteristic of Pex13s in other organisms such as Saccharomyces cerevisiae and
Arabidopsis thaliana. TbPex13.1 possesses an N-terminal YG rich region and an SH3
domain. In yeast, the YG-rich domain binds to Pex7 and the SH3 binds to Pex14 and
Pex5 (12, 15, 21). The YG-rich domain is the region with the highest similarity between
TbPex13.1 and TbPex13.2, having 36% sequence identity (Figure 4.1A). TbPex13.2
lacks an SH3 domain suggesting it does not bind to Pex5 and that the interaction with
Pex14 may be weaker than those occurring in other systems (14, 15, 21). Diagram of
predicted interactions of TbPex13.1 and TbPex13.2 shown in Figure 4.1B.
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Figure 4.1. TbPex13.1 and TbPex13.2 exhibit little similarity in primary structure but
do possess similar Pex13 domains.

(A) Alignment of the YG-rich domains of

TbPex13.1 and TbPex13.2. Consensus sequence for identical residues shown. Amino
acids represented by different colors.

(B) Domain organization of TbPex13.1 and

TbPex13.2. Putative interactions based on data from other systems are indicated by
dashed arrows.

TbPex13.1 and TbPex13.2 localize to punctate structures with similar density
To determine if TbPex13.1 and TbPex13.2 were in the same compartments, we used
super-resolution immunofluorescence microscopy.

Cells expressing epitope tagged

TbPex13.1 and TbPex13.2 exhibit punctate staining that is consistent with glycosome
staining. Interestingly, the two proteins exhibit limited signal overlap. While some of the
staining overlaps, there are regions of the cells that are labeled with only one protein (Fig
4.2A).

To compliment microscopy data, we used density gradient centrifugation to

determine if the Pex13s sediment in different fractions. We found that both TbPex13.1
and TbPex13.2 sediment in the same region of the gradient (fractions 8-11) with the
glycosome marker aldolase (Fig. 4.2B). BiP is shown as an ER marker, which sediments
in less dense fractions.
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Figure 4.2. TbPex13.1 and TbPex13.2 localize to similar cellular compartments. (A)
Cells expressing HATbPex13.1 and MycTbPex13.2 were fixed, permeabilized and stained
with antibodies against the HA and Myc epitopes. Maximum intensity projections shown.
Scale bar represents 5 μm. (B) Western blotting of density gradient fractions. Post-nuclear
supernatants were resolved on a 13 ml 20%-40% optiprep sucrose gradient. Fractions
(500 μl) were taken from the top and 2.5 μg protein from each fraction were analyzed by
SDS-PAGE and western blotting using antibodies against the ER protein BiP, glycosome
marker aldolase, and TbPex13.1 and TbPex13.2.

One hypothesis for the discrete signal of TbPex13.1 and TbPex13.2 is that they localize
to different glycosome populations and the observed overlap is a consequence of random
association of unrelated organelles.

We purified organelles from cells expressing

HATbPex13.1 and MycTbPex13.2 by immunoaffinity purification using magnetic anti-HA
and anti-Myc beads (28). If TbPex13s localize to discrete glycosome populations, we may
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observe differences in protein composition of the different samples. To confirm that the
isolated glycosomes were intact, we used scanning EM to visualize the glycosomes on
the surface of the beads (Fig. 4.3A).

To analyze protein content of the captured

organelles, samples were analyzed by SDS-PAGE and silver staining. Affinity purification
resulted in a less complex sample relative to total cell lysate with a similar staining pattern
as glycosome-enriched fractions obtained by sucrose gradient fractionation (SGF) (Fig
4.3B). We used western blotting to analyze specific glycosomal proteins. The matrix
proteins fructose 1,6-bisphosphatase (FBP), phosphofructokinase (PFK), and aldolase
were present in the samples, indicating that intact organelles were captured. (Fig 4.3C).
We used the mitochondrial protein HSP70 as a control for non-specific binding to beads.
We did not detect qualitative differences in the protein composition of the two affinity
purifications.
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Figure 4.3.

Immunoaffinity purification of glycosomes.

Cells expressing both

HATbPex13.1 and MycTbPex13.2 were mechanically lysed to preserve organelles and
the post-nuclear lysate was incubated with magnetic beads coated with antibodies for antiHA or anti-Myc. (A) Scanning electron micrograph images of anti-Myc and anti-HA beads
alone and after incubation with cell lysate. (B) Protein captured on the magnetic beads,
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total cell lysate, and glycosome enriched sucrose gradient fraction (SGF) were resolved
via SDS-PAGE and visualized by silver staining (Pierce). * denotes heavy and light chain
of antibodies on beads. (C) Samples in panel B were resolved by SDS-PAGE and
analyzed by western blotting with antibodies againstTbPex13.1, TbPex13.2, Pex14, and
GAT3, FBPase, PFK, and aldolase. HSP70 shown as a control.

Because we could not determine if there were organelles with only TbPex13.1 or
TbPex13.2, we used flow cytometry to analyze single organelles (Fig. 4.4). Cells were
lysed mechanically to release subcellular organelles and cell debris, nuclei, and large
organelles were removed via centrifugation. The resulting glycosome enriched fraction
was fixed, permeabilized, and stained with antibodies against HA and Myc. Unlabeled
organelles fell primarily in the lower left quadrant (Panel A) and single-stained controls
(Panels C and D) were gated to identify regions where glycosome populations possessing
only HATbPex13.1 or MycTbPex13.2 would fall on a bivariate plot. Dual-stained sample
(Panel B) fell primarily in the upper-right quadrant, indicating that of the particles
measured, 80% were positive for both HATbPex13.1 and MycTbPex13.2 while minimal
events appear in the single-stain gates. Due to the sensitivity required for organelle
detection, contaminants in the buffer were detected, and fell primarily in the lower-left
quadrant.
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Figure 4.4.

Flow cytometry analysis of individual organelles stained for

HATbPex13.1 and MycTbPex13.2. (A) Cells expressing epitope tagged Pex13s were
mechanically lysed and debris, nuclei, and large organelles removed by centrifugation.
The glycosome enriched fraction was fixed, stained using anti-HA and anti-Myc
antibodies, and analyzed by flow cytometry gated using SSC-width and FSC-H scatter
plots. (B) Dot plot of unlabeled organelles. (C) Dot plot of organelles labeled with antiHA and anti-Myc. Gating was performed using single-stained organelles to determine
where glycosomes possessing only TbPex13.1 (D) or TbPex13.2 (E) would appear.
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TbPex13.1 and TbPex13.2 directly interact with each other and Pex14
To determine if TbPex13.1 and TbPex13.2 physically interact, we performed targeted coimmunoprecipitation (Co-IP) with cells expressing HATbPex13.1 and MycTbPex13.2.
Cells were hypotonically lysed in the presence of IGEPAL to solubilize membrane
proteins. Lysates were then incubated with anti-HA or anti-Myc magnetic beads and
analyzed by western blotting (Fig. 4.5A). TbPex13.2 was detected in the anti-HA Co-IP,
and TbPex13.1 was detected in the anti-Myc Co-IP, indicating that both TbPex13.1 and
TbPex13.2 interact directly. Furthermore, Pex14 was detected in both TbPex13.1 and
TbPex13.2 co-IPs.

Identification of interacting proteins for both TbPex13.1 and TbPex13.2 was performed by
mass spectrometry.

TbPex13.1, TbPex13.2, and Pex14 were identified in both IP

samples. We detected several glycosomal matrix proteins including aldolase, FBPase,
and PFK. Identified proteins that are enriched at least 2-fold in the relative to the wildtype
control sample with annotated glycosomal localizations are summarized in Table 4.1.
Analysis of the glycosomal proteins that were identified in the Co-IP revealed that proteins
enriched in the anti-HAPex13.1 pulldown and absent in the MycTbPex13.2 pulldown were
primarily PTS1-containing proteins (Fig. 4.5B). Conversely, the proteins associated with
both HAPex13.1 and MycPex13.2 contained proteins harboring PTS1 and PTS2
sequences. Only 3 proteins were exclusively enriched in the anti-MycPex13.2 pulldown:
PGKA (suspected internal PTS), PGKC (putative PTS1) and the hypothetical protein
Tb11.01.2020 (unknown PTS). In addition to the known proteins, mass spectrometry also
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identified 44 hypothetical proteins enriched in either the HA or Myc IP such as
Tb11.01.2020 that are listed in Table 4.2.

Figure 4.5. TbPex13.1 and TbPex13.2 interact and form large complexes. (A) Cells
expressing HATbPex13.1 and MycTbPex13.2 were hypotonically lysed in the presence of
0.5% IGEPAL, incubated with either anti-HA or anti-Myc magnetic beads, and resolved by
SDS-PAGE and analyzed by western blotting. * denotes cross-reactive heavy and light
chain from magnetic beads.

(B) Analysis of glycosomal proteins that interact with

TbPex13.1 and TbPex13.2 by mass spectrometry. (C) Organelles isolated from PF cells
were resuspended in sample buffer containing 1% DDM, separated by blue native-PAGE
in the first dimension, resolved in the second dimension by SDS-PAGE and analyzed by
western blotting.
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Gene Name
or Symbol

Curated GO Processes

acetyltransferase, putative
phosphoglycerate kinase

PGKC

glycolytic process

Tb927.1.720

phosphoglycerate kinase

PGKA

Tb927.10.14720

peroxin 13

PEX13

Tb927.10.15410
Tb927.10.15850

glycosomal malate dehydrogenase
Peroxisome biogenesis factor 12

gMDH
PEX12

glycolytic process
peroxisomal membrane
transport;peroxisome
organization;posttranscriptional
regulation of gene expression
tricarboxylic acid cycle

Tb927.10.16120

inosine-5'-monophosphate dehydrogenase

IMPDH1

Gene ID

Product Description

Tb927.1.4490
Tb927.1.700

Tb927.10.240

peroxin 14, putative

Tb927.10.3080
Tb927.10.5620
Tb927.10.6150

+
+

Unknown
PTS1

+

+

Putative I-PTS

+

+

PTS1

+
+

+

PTS1
-

oxidation-reduction process;purine
nucleotide biosynthetic process

+

-

PTS1

PEX14

posttranscriptional regulation of
gene expression;protein targeting
to vacuole

+

+

-

ALD

glycolytic process

+
+
+

+
+
+

Putative PTS2
PTS2
PTS2

posttranscriptional regulation of
gene expression

+

-

Unknown

+
+
+

+

Putative PTS1
Putative PTS1
-

+

-

-

+
+

+
+

PTS1

+

-

-

GAT3

Tb927.11.14950

zinc finger protein 2

ZFP2

Tb927.11.3130
Tb927.11.3850

glycosomal transporter (GAT2)
AMP deaminase, putative

GAT2

Tb927.2.4130

enoyl-CoA hydratase/Enoyl-CoA isomerase/3hydroxyacyl-CoA dehydrogenase, putative

Tb927.3.3270
Tb927.3.3610
Tb927.4.3160
Tb927.4.4050

sedoheptulose-1,7-bisphosphatase
ATP-dependent 6-phosphofructokinase,
glycosomal
peroxisomal targeting signal 2 receptor,
putative
dihydroxyacetone phosphate
acyltransferase, putative
glycosomal transporter (GAT1)

transmembrane transport
cell differentiation;microtubule
polymerization
fatty acid transport

SBPase

fatty acid metabolic
process;metabolic
process;oxidation-reduction
process
carbohydrate metabolic process

+

-

PTS1

PFK

glycolytic process

+

-

PTS1

PEX7

protein targeting to peroxisome

+

-

-

TFEalpha1

DAT

ether lipid biosynthetic process

+

-

-

GAT1

fatty acid transport

+

-

-

+

+

PTS1

+

-

PTS1

+

-

PTS1

+

-

PTS1

+
+
+

+
+

PTS1
PTS1/PTS2
-

Tb927.5.2080

GMP reductase

GMPR

oxidation-reduction process;purine
nucleotide biosynthetic process

Tb927.5.3810

orotidine-5-phosphate decarboxylase/orotate
phosphoribosyltransferase, putative

PYR6-5

pyrimidine ribonucleotide
biosynthetic process

Tb927.7.330

Thioesterase-like superfamily, putative

Tb927.7.5680

deoxyribose-phosphate aldolase, putative

Tb927.9.6100
Tb927.9.8720
Tb927.9.9430

PTP1-interacting protein, 39 kDa
fructose-1,6-bisphosphatase
Peroxisomal membrane protein PEX13.2

Table 4.1.

PTS

-

methionine biosynthetic protein, putative
fructose-bisphosphate aldolase, glycosomal
neurobeachin/beige protein, putative
CCR4-NOT transcription complex subunit 10,
Tb927.10.8720
putative
Tb927.10.9890
hypothetical protein, conserved
Tb927.11.10260
hypothetical protein, conserved
Tb927.11.1070
glycosomal transporter (GAT3), putative

Tb927.2.5800

Present Present
in HA IP in Myc IP

PIP39
FBPase
PEX13.2

posttranscriptional regulation of
gene expression
protein dephosphorylation
carbohydrate metabolic process

Summary of glycosomal proteins identified by mass spectrometry.

Proteins were identified by mass spectrometry analysis of the precipitated protein.
Peptides that were enriched 2x relative to wild-type control, had a minimum of 10 hits, and
were annotated as glycosomal are listed. Also indicated is whether the protein was
detected in anti-HA or anti-Myc IPs and whether the protein harbors a PTS1 or PTS2.
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Gene ID

Product Description

hypothetical protein, conserved
hypothetical protein, conserved

# TM
Domains
0
0

Tb927.4.3070
Tb927.4.4530

hypothetical protein, conserved
hypothetical protein, conserved

# TM
Domains
0
0

Tb927.10.11370
Tb927.10.13800
Tb927.10.14700

hypothetical protein, conserved
hypothetical protein, conserved
hypothetical protein, conserved

0
0
0

Tb927.4.5120
Tb927.5.1130
Tb927.5.1840

hypothetical protein, conserved
hypothetical protein, conserved
hypothetical protein, conserved

0
3
0

Tb927.10.15310
Tb927.10.8090
Tb927.10.9350

hypothetical protein, conserved
hypothetical protein, conserved
hypothetical protein, conserved

0
0
0

Tb927.5.2150
Tb927.5.2560
Tb927.5.3330

hypothetical protein, conserved
hypothetical protein, conserved
hypothetical protein, conserved

0
1
0

Tb927.10.9890
Tb927.11.10260
Tb927.11.11050

hypothetical protein, conserved
hypothetical protein, conserved
hypothetical protein, conserved

0
0
0

Tb927.6.2190
Tb927.6.2210
Tb927.7.2780

hypothetical protein, conserved
hypothetical protein, conserved
hypothetical protein, conserved

0
0
0

Tb927.11.1620
Tb927.11.1850
Tb927.11.240

hypothetical protein, conserved
hypothetical protein, conserved
hypothetical protein, conserved

0
0
0

Tb927.7.3100
Tb927.7.7460
Tb927.8.1500

hypothetical protein, conserved
hypothetical protein, conserved
hypothetical protein, conserved

0
0
0

Tb927.11.3940
Tb927.11.5020
Tb927.11.6430

hypothetical protein, conserved
hypothetical protein, conserved
hypothetical protein, conserved

2
0
0

Tb927.8.2880
Tb927.8.5100
Tb927.8.7480

hypothetical protein, conserved
hypothetical protein, conserved
hypothetical protein, conserved

0
0
0

Tb927.11.6440
Tb927.11.7330
Tb927.11.8800

hypothetical protein, conserved
hypothetical protein, conserved
hypothetical protein, conserved

0
2
2

Tb927.9.12070
Tb927.9.6910
Tb927.9.7080

hypothetical protein, conserved
hypothetical protein, conserved
hypothetical protein, conserved

0
0
0

Tb927.3.2490
Tb927.3.4210

hypothetical protein, conserved
hypothetical protein, conserved

0
0

Tb927.9.8820
Tb927.9.9420

hypothetical protein, conserved
hypothetical protein, conserved

0
0

Gene ID

Product Description

Tb927.1.3070
Tb927.1.4230

Table 4.2. Hypothetical proteins identified by Co-IP analysis. Hypothetical proteins
found to interact with either HATbPex13.1, MycTbPex13.2, or both by coimmunoprecipitation. TM domains predicted by TMHMM analysis by TriTrypDB.

We used 2-dimensional blue-native / SDS-PAGE to determine the size of TbPex13.1 and
TbPex13.2 complexes (Fig. 4.5C). Organelles solubilized in 1% n-dodecyl-β-D-maltoside
were separated by BN-PAGE in the first dimension followed SDS-PAGE in the second
dimension. Both TbPex13.1 and TbPex13.2 are found in complexes with large molecular
weights (>480 kDa). TbPex14 signal is found in complexes with a molecular weight
between 212 kDa and approximately 900 kDa. Additional signal for both TbPex13s, but
not Pex14, is detected in complexes greater than 1,048 kDa. Additionally, TbPex14 signal
was detected in complexes lower than 480 kDa, suggesting that TbPex14 forms
complexes without TbPex13s.
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DISCUSSION
While Pex13 has been implicated in peroxisomal matrix protein import in several systems,
the exact role of Pex13 is not yet clear. In general, Pex13s are not well conserved;
however, they exhibit a conserved domain structure. An example of this is the low level
of sequence identity (27%) between Saccharomyces cerevisiae and Homo sapiens
Pex13s. Knockout of Pex13 in yeast and mammalian cell lines resulted in peroxisomal
“ghosts” that lack matrix proteins (4, 8, 29, 30). Truncation mapping of Pex13 in yeast
reveals that Pex13 interacts with Pex14 and Pex5 at the C-terminal SH3 domain and
interacts with Pex7 at the N-terminal YG-rich region (14, 31). Unique to kinetoplastids is
the presence of two distinct Pex13s that have low identity with each other. Pex13.1
possess all of the typical Pex13 domains; however, Pex13.2 possesses the YG-rich region
but lacks the SH3 domain. Knockdown of either Pex13.1 or Pex13.2 in T. brucei results
in mislocalization of glycosomal matrix proteins, and RNAi of Pex13.1 was shown to be
lethal (17, 23). Silencing of TbPex13.2 resulted in the mislocalization of PTS2 targeted
proteins (23). Because TbPex13.2 possesses only the YG-rich region, which is implicated
in Pex7 interaction in other systems, we hypothesized that this domain facilitates efficient
PTS2 protein import through interactions with Pex7 and glycosome specialization may be
a result of TbPex13.1 and TbPex13.2 localizing to different populations of glycosomes.

Because peroxisomes are heterogenous organelles in other systems such as yeast (3,
32), we hypothesized that TbPex13.1 and TbPex13.2 may function in specialization of
organelles. Using super-resolution immunofluorescence microscopy, we observed that
HATbPex13.1 and MycTbPex13.2 localize to punctate structures, and display regions
where signal intensity is not equal, suggesting that there may be heterogeneity in
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organelles expressing predominantly TbPex13.1 or TbPex13.2; however, we cannot
determine this by immunofluorescence microscopy alone.

Using density gradient

centrifugation to compliment the microscopy data, we did not observe a difference
between TbPex13.1 and TbPex13.2 sedimentation, indicating that both are found in
organelles with similar density.

Because we could not conclusively determine if TbPex13.1 and TbPex13.2 were found in
different compartments, we adapted a flow cytometry-based technique for the analysis of
single organelles. Organelles were isolated from cells expressing HATbPex13.1 and
MycTbPex13.2 by mechanical lysing and differential centrifugation to remove large debris
and organelles, and the glycosome enriched supernatant was fixed and stained with
antibodies against HA and Myc. Due to the small nature of glycosomes (100-250 nm
diameter), the sensitivity required for detection on the flow cytometer introduces
contaminating events detected from debris found in the buffer and in the sheath fluid.
Gating was performed on the SSC-W vs FSC-H scatterplot to decrease the amount of
debris, and secondary gating was performed using FSC-H vs FSC-A. The size gating was
performed because organelle size was directly related to fluorescence intensity. Using
this technique, the majority of dual-stained organelles were positive for both TbPex13.1
and TbPex13.2, indicating that both peroxins are found in the same organelles. To our
knowledge, this is the first time that flow cytometry has been used to analyze sub-cellular
organelles that have been processed and stained for membrane proteins. This flow
cytometry-based technique may be adapted for large scale analysis of various organelles
at an individual organelle level.
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Because the N-terminal epitope tags are cytosol facing, we used immuno-affinity
purification to purify organelles from cells expressing HATbPex13.1 and MycTbPex13.2
using magnetic beads coated with antibodies against HA and Myc epitopes. Capture of
intact glycosomes was confirmed via SEM analysis and we observed spherical particles
captured on the surface of the magnetic beads. Analysis of captured organelles by
western blotting revealed that there was not a significant difference between the content
of glycosomes captured on HA beads vs Myc beads.

Because TbPex13.1 and TbPex13.2 are found in the same organelles, we next examined
the composition of the docking and translocation module (DTM) in these organelles. We
sought to determine if the Pex13s are found in distinct complexes or as members of the
same complex. To analyze the protein-protein interactions of TbPex13.1 and TbPex13.2,
we used co-immunoprecipitation. Using cells expressing HATbPex13.1 and TbPex13.2,
we purified proteins that were physically interacting with the Pex13s using magnetic beads
with anti-HA or anti-Myc antibodies. Western blot analysis using antibodies against the
native TbPex13.1 and TbPex13.2 revealed that TbPex13.2 was captured in the anti-HA
IP and TbPex13.1 was captured in the anti-Myc IP, indicating that both peroxins interact
with each other. Additionally, Pex14 was detected in both samples, indicating that each
TbPex13 interacts with Pex14.

MS analysis revealed that 10 proteins interact with only TbPex13.1, 15 proteins interact
with both TbPex13.1 and TbPex13.2, and 3 proteins interact only with TbPex13.2.
Interestingly, a majority of the PTS1-containing proteins were detected in HATbPex13.1
only or in both HATbPex13.1 and MycTbPex13.2, but not only TbPex13.2. A majority of
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PTS2-containing proteins identified were enriched in detected in both HATbPex13.1 and
MycTbPex13.2 IPs (Fig. 4.5B). We hypothesize that PTS1 import is primarily facilitated
by TbPex13.1 while PTS2 import is facilitated by both TbPex13.1 and TbPex13.2. In
addition to the glycosomal proteins that were identified by co-IP, 44 hypothetical proteins
were also detected, which further analysis may reveal to be novel peroxins.

Homooligomerization of Pex13 has been demonstrated in mammalian fibroblasts and this
interaction was shown to be dependent on the N-terminal domain (20). By 2-dimensional
BN-PAGE/SDS-PAGE, we observed that both TbPex13.1 and TbPex13.2 are subunits of
large complexes that co-migrate by BN-PAGE, suggesting that both are capable of
oligomerizing with each other. Both Pex13.1 and Pex13.2 migrate in complexes with an
apparent molecular weight greater than 480 kDa, suggesting that there are multiple
subunits to these complexes, and is capable of a wide range of molecular weights.
Additionally, Co-IP of epitope tagged TbPex13.1 and TbPex13.2 results in reciprocal
immunoprecipitations, confirming the interaction between both peroxins. TbPex14 is
found in smaller complexes containing no detectable levels of TbPex13.1 and TbPex13.2,
suggesting that Pex14 is not always found in complex with Pex13.1 or Pex13.2
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Figure 4.6. Model for docking complex arrangement. The docking complex may be
comprised of a combination of TbPex13s: TbPex13.1 only, TbPex13.2 only, or a
combination of both. Because both TbPex13.1 and TbPex13.2 possess YG-rich domains,
PTS2 import would be equivalent in each of these complex arrangements; however,
because only TbPex13.1 has an SH3 domain, PTS1 import would only be facilitated by
complexes possessing TbPex13.1.

These findings suggest that both TbPex13.1 and TbPex13.2 are members of the
glycosomal docking complex, but the complex may form with different TbPex13 subunits.
There is the possibility of three types of docking complexes: TbPex13.1 only, TbPex13.2
only, and TbPex13.1 and TbPex13.2 (Fig 4.6). We hypothesize that the composition of
the docking complex would influence what proteins are effectively imported. For example,
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a complex made of solely TbPex13.1 would import PTS1 and PTS2 targeted proteins with
equal affinity, whereas the introduction of TbPex13.2 would shift the affinity to PTS2
import.

Summary
Because glycosomes are essential organelles, understanding mechanisms of biogenesis
and protein import are critical for taking advantage of the organelle as a potential drug
target. In this work, we examined the organization of the DTM in Trypanosoma brucei.
We found that both TbPex13.1 and TbPex13.2 are found in the same compartments and
interact with each other. Using MS analysis, we observed that a majority of the PTS1
harboring proteins were associated with HAPex13.1, while many PTS2 harboring proteins
were associated with both TbPex13.1 and TbPex13.2. These findings suggest that PTS1
import is primarily facilitated by TbPex13.1, while both TbPex13.1 and TbPex13.2 facilitate
PTS2 import. Additionally, we hypothesize that there are multiple possibilities for the DTM
composition: TbPex13.1 homooligomer, TbPex13.2 homooligomer, or TbPex13.1TbPex13.2 heterooligomer. The difference in DTM composition will likely influence the
proteins that are able to be effectively imported into the glycosome matrix.
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CHAPTER FIVE
Summary and Future Directions

Kinetoplastid parasites (Trypanosoma brucei, Trypanosoma cruzi, and Leishmania
spp.) are a persisting problem, particularly in developing regions of the world. Current
treatments for these diseases are typically expensive to transport and administer, with
some having very detrimental side effects, creating a need for new drugs. Of these
parasites, T. brucei is responsible for Human African Trypanosomiasis (HAT) and is
endemic across sub-Saharan Africa. Unique to kinetoplastids is the compartmentalization
of glycolytic and gluconeogenic reactions within specialized peroxisomes called
glycosomes.

Compartmentalization of many of these enzymes is essential, with

mislocalization of proteins such as HK resulting in cell death (1–4). Due to the essential
nature of glycosomes and the low level of similarity shared between kinetoplastid and
human peroxins, glycosomes pose an attractive drug target for HAT.
In Chapter Two, we analyzed the effects of extracellular glucose on gene
expression using both the lab adapted 29-13 strain as well as the pleomorphic Antat1.1
strain parasites. Prior work on T. brucei metabolism has shown that in the presence of
glucose, PCF parasites will preferentially utilize glycolysis rather than amino acid
metabolism (5). While lab-adapted PCF strains do prefer glucose, this is likely due to
routine culture in glucose-rich (~5 mM) media for decades. Our work has shown that the
pleomorphic AnTat1.1 strain parasites that are newly isolated from a murine host and
differentiated to PCF have an initial aversion to the addition of glucose (6). While the labadapted 29-13 strain parasites are commonly used and are more genetically tractable,
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use of the pleomorphic AnTat1.1 or similar isolates may prove to be a more relevant
system for study of PCF metabolism.
In addition to strain differences, prior studies in PCF T. brucei metabolism have
used culture medium such as SDM-79, containing 5 mM glucose, SDM-80 (5, 7–9), which
was formulated to simulate the conditions of the insect vector, or in “conditioned” SDM-79
(10, 11) in which cells have been cultured to deplete the media of glucose. Because PCF
parasites do not have constant glucose availability in the insect vector, it is more
physiologically relevant to study metabolic processes in the absence of glucose. Each of
these medias pose a different problem for studying the effect of glucose availability. Cells
grown in SDM-79 have adapted to the presence of glucose and do not appear to behave
as newly isolated PCF cells. SDM-80 is a “low glucose” medium, however, there are many
differences between SDM-79 and SDM-80 that confound the cell response to glucose
(Table 5.1). “Conditioned” SDM-79 is typically made by culturing cells in the media
containing 2x standard fetal bovine serum (FBS) to deplete the glucose. Cells are filtered
out and the media is diluted 1:2 with base media lacking FBS (11). This technique results
in media containing low glucose, however multiple other media components are
consumed by the cells and products are excreted by the cells. Similar to SDM-80, this
media differs from SDM-79 in components other than glucose. We are replacing SDM-80
with a modification of SDM-79, SDM-79θ, which serves to address these issues. Because
FBS has glucose, SDM-79θ uses dialyzed FBS in which small molecules have been
removed. The glucose concentration in SDM-79θ to be approximately 5 μM (6).
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Table 5.1. Media components in SDM-79 and SDM-80. SDM-80 varies from SDM-79,
making analysis of the effect of glucose alone difficult.

In Chapters Three and Four, we examine the role of the docking complex in protein
import into glycosomes. Glycosomes, like peroxisomes, lack DNA and all matrix proteins
must be imported post-translationally. Glycosomal matrix proteins are synthesized on free
ribosomes and are typically targeted with a peroxisomal targeting sequence (PTS) type 1
or type 2 (12). PTS1 is a C-terminal tripeptide that is recognized by the cytosolic receptor
peroxin Pex5 and is a conserved process among various organisms. PTS2 import is a
more variable process mediated by a N-terminal nonapeptide sequence that is identified
by Pex7 in concert with various co-receptors. The cytosolic receptors then direct the
bound cargo to the membrane docking/import complex on the glycosomal membrane
comprised typically of Pex13 and Pex14. Unique to kinetoplastids is the presence of two
Pex13s, Pex13.1 and Pex13.2, that do not share high levels of primary structure but have
similar domains (13).
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Previous work implicates both Pex13.1 and Pex13.2 in the glycosomal docking
complex, however the role of each peroxin is not understood (13–15). In Chapter Three,
I examine the role of TbPex13.2 in the glycosomal docking complex. We confirmed
previous findings that TbPex13.2 is an integral glycosomal membrane protein and
demonstrate that the N-terminus containing the YG-rich domain is exposed to the cytosol.
Using super-resolution immunofluorescence microscopy, we observed that TbPex13.2 is
found in discrete puncta on the glycosome membrane, which is consistent with the
localization of other membrane peroxins (16). Silencing of TbPex13.2 resulted in the
mislocalization of glycosomal matrix proteins harboring a PTS2, implicating it in the import
process. Additionally, silencing of TbPex13.2 did not result in a change in glycosome size
or shape when analyzed by transmission electron micrography, but did result in a
decrease in glycosome density as glycosomal markers sedimented higher on an optiprep
sucrose gradient.
In Chapter Four, I expand on our analysis of the glycosomal import complex.
Because kinetoplastids possess two Pex13s, we examined how the presence of
TbPex13.1 and TbPex13.2 influences the organization of the docking complex. While
TbPex13.1 and TbPex13.2 do not share high similarity in primary structure, they possess
similar domain structure. Like other Pex13s in yeast and mammals, TbPex13.1 has an
N-terminal YG-rich domain, 2 transmembrane domains, and a C-terminal SH3 domain. In
contrast, TbPex13.2 does not possess the SH3 domain. The YG-rich domain interacts
with Pex7 and other Pex13s, while the SH3 domain is able to interact with Pex5 and Pex14
(17–19). Because of these domain differences, we hypothesized that the presence of
TbPex13.2 may have implications for Pex14 interaction and formation of the
docking/import complex.
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We demonstrated that TbPex13.1 and TbPex13.2 localize to the same organelles.
Initial super-resolution immunofluorescence microcopy suggested localization of both
peroxins to glycosomes and the sedimentation of the peroxins on a density gradient
centrifugation matched that of other known glycosomal markers.

Using a cell line

expressing HATbPex13.1 and MycTbPex13.2, we immunoaffinity purified intact
glycosomes from post-nuclear supernatant using magnetic beads coated with anti-HA or
anti-Myc antibodies. Analysis of protein content found in these organelles by western
blotting showed that glycosomal matrix proteins were detected, but no qualitative
difference in protein composition between the organelles purified using anti-HA or antiMyc beads was observed.

Additionally, we developed a new flow cytometry-based

method for examining localization of proteins in glycosomes.
organelle

samples

were

prepared

from

cells

expressing

Glycosome enriched
HATbPex13.1

and

MycTbPex13.2 and were fixed, permeabilized, and stained using anti-HA and anti-Myc
antibodies. Secondary antibodies conjugated to Alexa405 and Pacific orange which are
excited using the 405nm laser were used to detect particles with a theoretical limit of
detection of ~200 nm. Using this method, we demonstrated that all of the events detected
were found to be positive for both HATbPex13.1 and MycTbPex13.2. Based on these
data, we have shown that TbPex13.1 and TbPex13.2 are found in the same organelles.
Because interaction between Pex13s is mediated by the YG-rich domain, we
hypothesized that TbPex13.1 and TbPex13.2 would be able to interact with each other.
We

used

co-immunoprecipitation

using

cells

expressing

HATbPex13.1

and

MycTbPex13.2 to determine the interactions of both TbPex13s. Cells were hypotonically
lysed in the presence of 0.5% IGEPAL and were incubated with magnetic beads coated
with anti-HA and anti-Myc antibodies. Proteins captured on the magnetic beads were
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analyzed by western blot and mass spectrometry. TbPex13.1, TbPex13.2 and Pex14
interacted with each other. Additional TbPex13.1 and TbPex13.2-binding proteins were
identified by mass spectrometry. A majority of PTS1 proteins were enriched in the antiHAPex13.1 co-IP, whereas PTS2 proteins were found in both samples, suggesting that
PTS1 proteins interact primarily with Pex13.1, while PTS2 proteins are capable of
interacting with both peroxins. Hypothetical glycosomal proteins such as Tb11.01.2020
were identified by mass spectrometry and show decreased fitness in a high-throughput
RNAi screen, which may be interesting candidate proteins to follow up on.
To determine the composition of the docking complex, we used 2 dimensional blue
native (BN)/SDS-PAGE. Cells were lysed and organelle-enriched pellets were prepared
by differential centrifugation, resuspended in sample buffer and separated by first
dimension BN-PAGE to resolve complexes by size. Second dimension SDS-PAGE was
used to resolve subunits of the complexes. Using this method, we were able to detect
complexes containing TbPex13.1 and TbPex13.2 between 480 kDa and approximately
1,100 kDa and complexes containing TbPex14 between 212 kDa and ~900 kDa. These
data suggest that complexes containing all three peroxins exist, but TbPex14 is found in
smaller complexes lacking TbPex13.1 or TbPex13.2, and TbPex13.1 and TbPex13.2 are
found in larger complexes lacking detectable TbPex14.
We hypothesize that the presence of two Pex13s allows for variation in the docking
complex.

TbPex14

may

bind

with

TbPex13.1

homooligomers,

TbPex13.2

homooligomers, or TbPex13.1-TbPex13.2 heterooligomers, and this is likely to impact
import efficiency. One model states that the import efficiency of PTS1 proteins decreases
with increasing amounts of TbPex13.2 in the docking complex because TbPex13.2 lacks
the SH3 domain implicated in Pex5 interactions (Fig. 4.6). Future work may be able to
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determine if complex formation between TbPex13.1 and TbPex13.2 may play a role in
glycosome heterogeneity.

Organelle heterogeneity is difficult to study using current

techniques. Immunofluorescence microscopy is not amenable to high-throughput assays
and artifacts from antibody staining may make analysis difficult. Analysis of organelles
isolated using density gradient centrifugation does not allow for measurement of individual
organelles with similar densities. The flow cytometry-based method for single organelle
analysis described in Chapter Four allows for a high throughput, multi-factor analysis of
organelle content for future studies.
Understanding of glycosome dynamics is critical for viewing them as a target for
treatment of disease caused by kinetoplastid parasites. The essential nature of the
organelles combined with the low level of similarity of kinetoplastid peroxins with
mammalian peroxins provide an attractive drug target.

We have demonstrated that

glucose availability plays a role in glycosome protein abundance and a standardized
media composition is crucial for the study of these organelles and other metabolic
processes. We have also begun to understand the mechanisms that regulate import of
proteins into the matrix of glycosomes. While the key proteins involved in the import
pathway are known, the mechanism of protein docking and translocation are not well
understood. In kinetoplastid parasites, the presence of two Pex13s complicates the
docking complex, but may serve as a useful tool in studying the docking and import
processes that may be able to be translated into other model systems.
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